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Sickle cell disease (SCD) is one of the most common autosomal-recessive genetic 
disorders affecting millions worldwide. The three most significant abnormal features 
of RBCs from SCA patients are haemoglobin (HbS) polymerisation, 
phosphatidylserine (PS) exposure and significantly increased cation permeability via 
the KCl cotransporter (KCC), and are critical to the pathogenesis of SCD. The 
outcome of these abnormal features usually results in altered red blood cell (RBC) 
fragility and rheology, increased viscosity with blockage of small capillary vessels, 
and changed RBC membrane permeability. This study aimed to explore novel aspects 
of these three features with respect to their modulation by physiological stimuli 
experienced in vivo and a major pharmacological modulator, protein phosphorylation. 
Various physiological stimuli such as oxygen tension (PO2), rate of deoxygenation, 
pH, urea, anisotonicity and medium composition, play an important role in regulation 
of HbS polymerisation, PS exposure and KCC activity in HbSS RBCs. In addition, low 
potassium (LK) sheep RBCs were utilised as an animal model to examine these 
physiological stimuli on KCC activity in comparison with their effects on human HbSS 
RBCs’. Various pharmacological manoeuvres were also tested for their effects on HbS 
polymerisation, PS exposure and KCC activity. A key finding was the marked 
stimulatory effect of the pan “with no lysine” kinase inhibitor WNK463 on KCC activity 
in HbSS RBCs, indicative of a critical role for WNK kinases in control of KCC in RBCs. 
However, there was no pharmacological evidence for the downstream involvement 
of SPAK/OSR1, although definitive evidence awaits phosphoproteomic studies. 
Overall, results provide a better and more comprehensive understanding of the 
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1.1 Sickle cell disease 
The discovery of sickle cell disease (SCD) in Western medicine can be traced back to 
1910. A dental student Walter Clement Noel, from the Caribbean island of Grenada, 
was diagnosed with pulmonary symptoms by two Chicago physicians, Dr James 
Herrick and Dr Ernest Irons (Herrick, 2014). Irons firstly described Noel’s red blood 
cells (RBCs) as “having the shape of a sickle”, which then inspired the cardiologist 
Herrick to consider that it might be a disease sui generis. Herrick then published a 
paper in the Yale Journal of Biology and Medicine, coining the term “sickle-shaped 
cells”. In Herrick’s clinical report, he offered only sketchy details of a characteristic 
feature of SCD: “elongated, sickled cells” (Herrick, 2014). However, this clinical report 
still quickly drew Western clinicians’ attention. Later, it was defined as a genetic 
disease in which most patients had the homozygous genotype HbSS rather than HbAA 
of normal people. Moreover, heterozygotes AS (HbAS) patients (also called sickle trait 
individuals) appeared to be relatively asymptomatic although their RBCs could still be 
induced to become sickled ex vivo. 
In 1949, the Nobel prize laureate Dr Linus Pauling and his colleague Dr Harvey Itano 
discovered that haemoglobin had different biological properties in SCD patients. They 
utilised the cutting-edge biotechnology of that time, gel electrophoresis, to examine 
the difference of haemoglobin mobility among SCD individuals, sickle trait individuals 
and normal people. The differences in mobility which were obtained, indicated charge 
differences and therefore an altered haemoglobin structure of HbS compared to that 
of HbA. The disease was then defined by Linus Pauling in his paper, entitled “Sickle 
cell anemia, a molecular disease” (Pauling et al., 1949). 
Since then, the pathophysiological mechanism of SCD has been gradually unmasked 










SCD was originally confined to the tropics and subtropics, where it was endemic in 
many countries, but is now common worldwide due to globalisation and migrations. 
Nowadays, approximately 5% of the world’s population carries genes for haemoglobin 
disorders, the most common of which are SCD and thalassemia. The global distribution 
of haemoglobin disorders is shown in Figure 1.1. The most common areas for SCD 
patients are Africa, the Middle East, South America, Central America, India and some 
Mediterranean countries (Greece, Turkey and Italy). According to a World Health 
Organisation (WHO) report in 2008 and Piel et al.’s report in 2010, more than 350,000 
new-born babies suffer from a severe haemoglobin disorder (including SCD and 
thalassemia) each year. Approximately 80% of affected children are born in poor or 
developing countries, with a lethality of 3.4% in children aged under five years old.  
Geographically, due to globalisation, approximately 50 million heterozygous HbS 
individuals have spread throughout the world nowadays, being found in 290 countries. 
Evidence also indicates that more than 9 million carriers become pregnant annually, 
thus increasing the number of people carrying the sickle gene (Modell and Darlison, 
2008; Piel et al., 2013). In Africa, approximately 10% – 40% of the population carries 
the HbS mutation. In the U.S., the incidence of SCD patients is 1 SCD new-born baby 
in 600 births in the African-American population (African heritage). SCD affects 
approximately 60,000 – 70,000 people living in the U.S. In France, there were 405 
new-born SCD babies in 2007 and a total of approximately 10,000 people were 







Figure 1.1 Global distribution of pathological haemoglobin disorders. The people living in the darkest 
area are suffering from more than 19 affected new-born babies per 1,000. The rest of the world 
presents a reduced prevalence of SCD. Haemoglobin disorders including sickle cell disease are usually 
found in poor and developing countries partly due to the absence of prenatal diagnosis. SCD patients 
are mainly found in Africa, Middle East, South America, Central America, India and some Mediterranean 





















In normal adult human RBCs, the molecular weight of one HbA is 64 kDa, existing as 
a tetrameric 2α2β polypeptide globin chain. In the centre of each polypeptide chain, 
Fe2+ is embedded in a heme group within a porphyrin ring, making the haem molecule 
able to bind to an oxygen (O2) molecule reversibly (Steinberg, 1998). HbA functions 
as an oxygen-binding metalloprotein, delivering O2 from lung to other organs of the 
human body via the cardiovascular system (Sidell & O’Brien, 2006). The structure of 
Hb can be changed by binding of O2 to each of the four Fe2+. Under hypoxic 
environment, Hb becomes deoxygenated, which is in the “tense shape” (T), rather 
than the “relaxed shape” (R) in oxygenated environment. Some other gases such as 
carbon dioxide (CO2) and nitric oxide (NO), which also have various physiological 
functions, are also carried by haemoglobin throughout the human body.  
SCD arises from a gene defect on the short arm of chromosome 11 (11p15.5), which 
encodes β haemoglobin, and contains a point mutation (GAG to GTG) which changes 
the amino acid from glutamic acid (negative charge) to valine (uncharged) at the 6th 
amino acid of the β chain, enabling a hydrophobic interaction with another 
haemoglobin molecule. Under the deoxygenated environment, the presence of HbS 
causes a tendency of haemoglobin to polymerise to form an elongated rope-like fibre, 
which distorts the morphology of RBCs into sickle shape (C-shape), resulting in RBCs 
lesions. The accumulated rigid RBCs are responsible for the complications of SCD such 
as vaso-occlusion and acute chest syndrome which are hallmarks of the disease 
(Pauling et al., 1949; Ingram, 1957; Marotta et al., 1977). 
 
1.3.2 HbS polymerisation, crystal-solution equilibrium and sickling 
As referred to in section 1.3.1, HbS molecules in SCA patients aggregate and form 14-
membered polymers or fibres under hypoxic environment, in which valine from one 
HbS molecule binds to leucine, phenylalanine and alanine from an adjacent HbS 
molecule by forming hydrophobic bonds (Ingram, 1957). There are physiological 
factors which may alter the formation of HbS: high intracellular [HbS], oxygen tensions, 
low pH, urea, low Mg2+ and high temperature (Eaton & Bunn, 2017). 
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The polymerisation of sickle haemoglobin is an equilibrium between insoluble HbS 
crystals and dissolved HbS in solution. The kinetic features of HbS polymers formation 
underlie the critical determinants of sickle RBCs morphology. There is a delay time (TD) 
for the formation of haemoglobin polymers following deoxygenation. Polymerisation 
consists of a two-pathway mechanism including homogeneous nucleation and 
heterogeneous nucleation (Ferrone et al., 1980). Homogenous nucleation occurs when 
haemoglobin polymers form through an unstable polymerisation, followed by the 
second pathway, the heterogeneous nucleation, which is located on the surface of 
these initial polymers (Ferrone et al., 1980) (Figure 1.2). Robust evidence indicates 
that SCD would become a milder disorder in the presence of only homogeneous 
nucleation (Bunn, 1997). Moreover, if HbS in sickle RBCs does not undergo 
heterogeneous nucleation events, deoxygenated sickle cells will take a longer time to 
form fully sickled RBCs and the delay can be enough for cells to return to the lungs 
before forming insoluble polymers (Mirchev & Ferrone, 1997). If sickle RBCs are 
exposed to a profoundly hypoxic environment, homogeneous nucleation is favoured, 
and the haemoglobin polymerisation events will result in a granular or cobblestone 
texture, which does not distort the biconcave shape of HbS-containing RBCs as much 
and has a milder disorder. In contrast, if HbSS RBCs are slowly deoxygenated or 
exposed to less profound hypoxia, haemoglobin S fibres will form in RBCs through 
both nucleation events, thereby altering the shape of RBCs to a greater extent, 
producing more severe complications (Mozzarelli et al., 1987). 
Moreover, some sickle HbS RBCs do not depolymerise when re-oxygenated. These 
RBCs are believed to have membrane protein and cytoskeletal abnormalities and are 
referred to as irreversibly sickled cells (ISCs). ISCs are more prone to haemolysis than 





Figure 1.2 The formation of HbS polymer: (A) in the deoxygenated state, adjacent HbS molecules 
bind to each other via their β chains (Bunn, 1997); (B) cross section of HbS polymer presenting as 7 
double-stranded helical structures which form a rope-like structure (Eaton & Hofrichter, 1990). 
 
1.4 Phosphatidylserine (PS) exposure in SCD 
Normally, the regular life span of human RBC is about 120 days, after which they 
become old and can be eliminated phagocytically by macrophages. In SCD patients, 
the life span of their RBC is much shorter at about 10-20 days, leading to severe 
complications such as stroke, acute chest syndrome and pulmonary hypertension, etc 
(McCurdy & Sherman, 1978; Steinberg, 2008; Rees et al., 2010; Chakravorty & 
Williams, 2015). In the healthy RBC membrane, the aminophospholipids 
phosphatidylethanolamine (PE) and phosphatidylserine (PS) are in the inner side of 
RBC membrane, while the sphingomyelin (SM) and phosphatidylcholine (PC) are on 
the outer side of membrane bilayer (Kuypers, 2007). More types of phospholipids such 
as phosphatidylinositol (PI) and cholesterol play an important role in providing RBC 
plasma membrane functional fluidity and asymmetry, which in turn ensures stability 
and integrity of RBCs. The negatively charged PS, when exposed on the red cell 
surface, could allow adherence of other cell types such as endothelial cells and 
macrophages during microcirculation. A glycoprotein secreted by macrophages, 
lactadherin (LA), provides a PS-binding motif for the detection of PS-expressing RBCs 
(Verhoven et al., 1995; Dasgupta et al., 2008; Leventis & Grinstein, 2010) (Figure 
1.3). Moreover, the externalised PS can also be recognised by an adhesion receptor 
expressed by activated endothelia cells (Yamaja Setty et al., 2002; Yamaja Setty & 
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Betal, 2008). Overall, PS exposure can be seen in some haematopoietic cells such as 
RBCs, lymphocytes and platelets, which is an early signal of programmed cell death 
(Zwaal & Schroit, 1997; Zwaal et al., 2005). As one of the hallmarks of SCD, PS 
exposure in HbSS RBCs is 2-11% higher than that in healthy human RBCs (Kuypers 




Figure 1.3 Schematic diagram of the phospholipid composition of RBC membrane containing with two 
important membrane transport systems: flippase and scramblase. The Ca2+-activated coagulation 
cascade (factor Va, Xa and II) and phosphatidylserine (PS) is attractive to macrophages. SM: 
Sphingomyelin, PC: Phosphatidylcholine, PE: phosphatidylethanolamine, PS: Phosphatidylserine (Stuart 
& Nagel, 2004). 
 
The mechanism of the externalisation of PS still remains unidentified. However, the 
deoxygenation-induced HbS polymerisation and sickling shape change has been 
suggested to play a role in inducing PS exposure of HbSS RBCs (Lubin et al., 1981; 
Blumenfeld et al., 1991; De Jong et al., 2001). Two membrane transport systems, 
which are the aminophospholipid translocase (APLT or flippase) and the scramblase 
(phospholipid scramblase), are responsible for maintaining the normal phospholipid 
distribution (Figure 1.3). The flippase, the first transport system, is an ATP-dependent 
primary active transport system, which is homologous to the P-type ATPase and a 
subfamily of P4-ATPase, functioning as transporting PE and PS from the outer 
membrane to the inner membrane (Seigneuret & Devaux, 1984; Daleke & Lyles, 2000; 
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Daleke, 2007). The second transport system, the scramblase (PLSCR, or phospholipid 
scramblase), is suggested as a phospholipid transporter, which can be activated by 
Ca2+ and moves lipids bidirectionally (Barber et al., 2009). Normally, the scramblase 
remains inactivated in healthy RBCs. However, the scramblase becomes activated in 
the presence of Ca2+, whose entry is mediated by Psickle (see later), suggesting a role 
of Ca2+ in the mechanism of PS exposure. Pharmacologically, the ionophore Br-A23187 
has been widely utilised in making RBC membrane highly permeable to Ca2+ (Bevers 
& Williamson, 2010). Owing to this method, the free [Ca2+]i can be fixed and calculated 
by utilising the Donnan ratio (Flatman, 1980; Muzyamba et al., 2006).  
Since then, studies have proposed that Ca2+ may activate the scramblase and inhibit 
the flippase. The scramblase can activated when [Ca2+] is about 100 μM in vitro (Kamp 
et al., 2001), although more recent estimates indicate a much higher Ca2+ affinity of 
a few micromolar (Weiss et al., 2012; Cytlak et al., 2013), while the flippase can also 
become inhibited when [Ca2+] is about 0.2-1 μM in vitro (Bitbol et al., 1987). The 
localisation of PS is partially determined by the ratio of activities of flippase to 
scramblase (F/S ratio), with a high F/S ratio leading to the internalisation of PS and 
vice versa (Barber et al., 2009). In HbSS RBCs, the Gardos channel also becomes 
activated with a Ca2+ threshold of about 100 nM (Lew & Bookchin, 2005; and see 
later), leading to cell dehydration and further PS exposure under hypoxic environment. 
 
1.5 Pathways of abnormal transport in sickle RBCs  
Isosmotic dehydration of sickled RBCs in vivo may be the consequence of the 
activation of one or various transporters located on RBCs plasma membranes. The 
predominant transport systems are represented by: (1) the deoxygenation-induced 
cation pathway (Psickle); (2) the Ca2+ -activated K+ channel of intermediate 
conductance (or Gardos channel), which is cloned and is represented by IK1 (hSK4) 





Figure 1.4 Schematic diagram of the three transport systems involved in dehydration of sickle RBCs. 
High cation permeability occurs in sickle RBCs caused by three highly active transport pathways. In the 
oxygenated sickle RBCs, KCC remains active and induces the loss of K+ and Cl-; Psickle and Gardos 
channel remain relatively quiescent. In deoxygenated RBCs, KCC is still active; Psickle and Gardos channel 
are also activated. Psickle is deoxy-dependent and activated by the polymerisation of HbS and plays an 
important role in mediating the entry of Ca2+. The Gardos channel is then activated through increased 
concentration of intracellular Ca2+, which further increases the concentration of HbS and promotes HbS 
polymerisation (taken from Hannemann et al., 2011). 
 
1.5.1 The deoxygenation-induced cation pathway (Psickle) 
Psickle is triggered by deoxygenation of sickle RBCs. Nowadays, Psickle is described as an 
unidentified non-specific cation channel(s) which is/are activated physiologically 
(Ranney, 1997). Several important works carried out by Joiner and colleagues tried to 
elucidate the role of Psickle in mediating the entry of Na+ and the loss of K+ in sickle 
RBCs (Joiner et al., 1986). They primarily found out that under the circumstances of 
PO2 less than 40 mmHg, supplemented with extracellular divalent cations, the loss of 
K+ is greater than the entry of Na+, representing the major cause of RBC dehydration 
(Joiner et al., 1995). Some early research was carried out by Lew and his colleagues, 
who endeavoured to elucidate the nature of Psickle in 1990s. After carefully comparing 
HbSS RBCs with normal RBCs, they found out that the reason for dehydration of sickle 
cells is the enhanced permeability of Ca2+ in HbSS RBCs. They observed that the 
dehydration of sickle cells was deoxy-dependent with the presence of Psickle in dense 
/ dehydrated reticulocytes (Bookchin et al., 1991). Moreover, to restore the balance 
of Na+ and K+, Na+/K+ pump (3:2 Na+/K+ flux ratio) consumes energy by hydrolysing 
ATP and then leads to further solute loss (Post et al., 1967; Joiner et al., 1986). 
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To summarise, the existence of Psickle will enhance the entry of Ca2+, and the loss of 
some other cations such as Mg2+ in sickle RBCs in the deoxygenated state. The entry 
of Ca2+ plays a particularly important role in activating the second transport pathway, 
the Gardos channel (Rhoda et al., 1990). Loss of Mg2+ via Psickle may also be important 
in activating KCC through alteration of the balance of kinase and phosphatase activities 
which are implicated in its regulation - see later. 
 
1.5.2 The Gardos channel 
The Gardos channel of human RBCs was first discovered by Gyögy Gárdos in 1958 
(Gárdos, 1958). The Gardos channel in RBCs plasma membrane, belongs to a family 
of Ca2+-activated K+ channels of intermediate conductance. It is encoded by KCNN4 
gene. The Gardos channel ubiquitously exists on the membrane of RBCs and 
approximately 150 channels exist per mature erythroid cell (Wolff et al., 1988). Due 
to the high capacity of the Gardos channel, it functions as a gatekeeper of calcium-
activated potassium efflux. In various cell lines and tissues, it can mediate normal and 
pathological roles such as immunologic function, cardiovascular system, asthma and 
neuroprotection (Christophersen & Wulff, 2015). 
Owing to inherent difficulties, it is currently difficult to crystallise the Gardos channel, 
with implicit problems for analysis of its structure. Conventional methods to analyse 
Gardos channels, such as NMR spectroscopy and X-ray crystallography, only provide 
a potential structure. Hence, the structure of the Gardos channel is predominantly 
deduced from the known structures of other similar proteins (Vandorpe et al., 1998). 
As shown in Figure 1.4, the basic structure of the Gardos channel is thought to 
comprise the six transmembrane domain (TMD) polypeptides (s1 – s6 domains), 
accompanied by one “pore” region. The channel in the RBCs plasma membrane exists 
as a homotetramer (Doyle et al., 1998). The major functional motif of Gardos channel 
are the “p” regions, which function as the selectivity filter and pore. The movement 
of K+ is mediated by the carbonyl oxygen atoms within the “p” region protruding from 





Figure 1.4 The structure of the Gardos channel. Six putative TMDs (s1-s6) and the “p” domain form 
the channel, which serves as selectivity filter and pore (Vandorpe et al., 1998). The main functional 
entity of the channel is predicted as a tetramer (Vandorpe et al., 1998). 
 
In normal HbAA RBCs, the intracellular concentration of Ca2+ (~20-50 nM) is kept low 
by the plasma membrane calcium pump (PMCA, in human isoforms of PMCA1 and 
PMCA4), at which the Gardos channel is normally inactive (Lew et al., 1982; Gibson & 
Ellory, 2002). However, in sickle cells, the Gardos channel is activated by elevated 
[Ca2+] (~100-150 nM, the entry of Ca2+ is via Psickle transport pathway) (Bennekou et 
al., 2004; Lew & Bookchin, 2005). Robust evidence shows that highly activated Gardos 
channels in RBCs mediate a marked loss of K+ with Cl- and water, leading to RBC 
shrinkage, [HbS] elevation and acceleration of HbS polymerisation (Brugnara et al., 
1993; Etzion et al., 1993). 
 
1.5.3 The KCl Cotransporter (KCC) 
KCCs are expressed in a large variety of cells such as RBCs, tumour cells and 
hepatocytes, which have the potential to mediate regulatory volume decrease (RVD) 
following cell swelling (Lauf et al., 1992; Shen et al., 2003). In 2005, Crable et al. 
indicated that there are three KCC isoforms in the RBC membrane, which are KCC1 
(SLC12A4, on chromosome 16q22), KCC3 (SLC12A6, on chromosome 15q14) and 
KCC4 (SLC12A7, on chromosome 5p15) (Crable et al., 2005). All three KCC isoforms 
have twelve TMDs, some N-glycosylation sites occur between TMD-5 and TMD-6, and 
cytoplasmic amino and carboxyl terminal domain (Figure 1.5). The TMD-2 plays a role 
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in mediating cation transfer (Isenring & Forbush, 2001; Bergeron et al., 2006). In 
RBCs from normal individuals and SCD patients, KCC can mediate solute loss and alter 
cell volume (Quarmyne et al., 2011). However, when normal individual RBCs become 
mature (aging), the activity of KCC progressively decreases but can still be partially 
activated by in vitro pharmacologically incubating with thiol-reactive agents such as 
N-ethylmalemide (NEM) (Lauf et al., 1985). Its physiological role is probably to 
mediate the reduction in RBC volume as erythroblasts mature into erythrocytes. 
 
 
Figure 1.5 The structure of KCC. KCC has twelve TMDs. From domain 1 to domain 10 are definite 
segments (grey). Domain 11 and domain 12 are putative segments (white). NTD (N-terminal domain) 
and CTD (C-terminal domain) occur in the cytoplasm. ECL represents extracellular loop. ICL represents 
intracellular loop (Zhang et al., 2005).  
 
In sickle RBCs, abnormal KCC activation can induce the loss of intracellular potassium 
and chloride with water following osmotically via other channels (aquaporins), leading 
to RBCs shrinkage, [HbS] elevation and HbS polymerisation acceleration, which in turn 
induce the red cells to sickle (Quarmyne et al., 2011). In SCD patients, the details of 
KCC activation are complex and remain unclear, with various possible physiological 
stimuli including low pH, urea, volume and Mg2+ depletion (Jennings & Al-Rohil, 1990). 
Moreover, it is also proposed that KCC is bound to the N-terminal of band 3 
cytosolically, and that the activation of KCC might follow polymerisation of HbS and 
RBC shape distortion (Gibson & Ellory, 2002). Pharmacological evidence and molecular 
biology indicate that KCC is regulated by protein phosphorylation / dephosphorylation, 
via cascades of regulatory protein kinases and phosphatases such as protein kinases 
Syk and Src and phosphatases PP1 and PP2A (Bize et al., 1999; Merciris et al., 2003). 
Moreover, WNK/SPAK/OSR pathway has been suggested to inhibit KCC by 
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phosphorylation in HEK293 cell lines but also in red cells (Rinehart et al., 2009). Also, 
some other serine-threonine protein phosphatase inhibitors such as NEM and okadaic 
acid have suggested to be potent physiological blockers of KCC (Jennings & Schulz, 
1991). Overall, KCC activation has been concluded to act as a net dehydration event, 
which is associated with solute loss and water dehydration. 
Another important feature of KCC in RBCs from SCD patients is its abnormal response 
to oxygen tension. In normal RBCs, KCC is inactivated at low oxygen levels, and the 
main stimuli associated with KCC activation – low pH and urea – are found is hypoxic 
regions. This means that KCC in normal RBCs cannot respond to these major 
physiological stimuli.  In sickle cells, however, KCC activity at first reduces as oxygen 
tension is lowered, but at about the P50 for Hb saturation, KCC activity increases again, 
such that in fully deoxygenated RBCs, KCC activity is actually higher than in fully 
oxygenated ones (Gibson et al., 1998, 2001). This is significant because it means that 
in sickle cells, KCC activity can be stimulated by low pH and urea even in hypoxic 
regions, and thereby mediate solute loss and RBC dehydration. 
 
1.6 KCC in LK (low potassium) sheep RBCs 
In 1954, Evans and colleagues found that the [K+] in sheep RBCs is genetically 
controlled being either high K+-containing (HK) or low K+-containing (LK) (Evans, 
1954). In HK sheep RBCs, high activity of the Na+/K+ pump occurs on the RBC 
membrane together with a low passive K+ leak; while conversely in LK sheep RBCs, 
there is no Na+/K+ pump activity, and a high passive K+ leak (Tosten & Hoffman, 1960; 
Dunham, 1976). This phenomenon is the consequence of Mendelian inheritances, 
controlled by a single gene with two alleles, l and m, determining whether sheep RBCs 
become HK or LK (Evans and King, 1955; Rasmusen and Hall, 1966). Homozygous 
mm sheep have HK RBCs. In young sheep’s RBCs or precursor RBCs, all RBCs also 
present as HK. Sheep of the ll genotype or heterozygous lm have LK RBCs when they 
are mature. RBCs from these animals have a particularly high activity for KCl 
cotransporter (Brown et al., 1978; Dunham & Ellory, 1981). Hence, mature LK sheep 
is a good animal model for studying KCC, to characterise this Cl-dependent, volume-
sensitive transport pathway and it has been much studied, making it a particularly 




1.7 Treatment of SCD 
Since the discovery of SCD by James Herrick in 1910, the treatment of SCD remains 
largely supportive although there has been considerable effort to design more specific 
therapies. Hydroxyurea (hydroxycarbamide or HU) therapy has been invented and 
utilised to treat SCD from the 1995 onwards (Charache et al., 1995). The mechanism 
of HU therapy is to enhance the transcription of the gamma (g) chain of haemoglobin, 
which in turn increasing the level of fetal haemoglobin G (HbF) (its biological structure: 
a2g2 instead of a2b2), attenuating the severity of SCD by preventing HbS molecules 
polymerisation (Watson, 1948; Covas et al., 2004). Even so, the exact mechanism of 
HU therapy remains unclear. However, the HU therapy has been suggested to have 
some toxic side effects to human body and furthermore is teratogenic so that its use 
is largely confined to more severely affected SCD patients (Vasavda et al., 2008; Rees, 
2011; Strouse & Heeney, 2012). Traditionally, exchange transfusion and regular blood 
transfusion have been utilised for the SCD management. Though blood transfusion 
can attenuate the severity of SCD, tissue damage and some other complications in 
SCD patients may be caused by the resulting iron overload, haemorrhagic 
complications and blood transmitting infections (Embury, 1996; Agble et al., 1998; 
Swerdlow, 2006). In addition, penicillin, an antibiotic drug, has been utilised as a 
complimentary disease management in SCD patients, especially to increase the 
survival rate of SCD children by preventing pneumococcal sepsis infection (Rees, 
2011). However, there is an urgent need for developing new drugs or a combination 
of several drugs to increase the level of HbF but with milder side-effects than HU 
therapy or to attenuate the condition by some other mechanisms (Ataga, 2009). 
More recently, some other treatment strategies have been investigated to control HbS 
polymerisation, prevent sickling, increase HbS oxygen affinity, increase the 
dehydration of RBCs, inhibit platelet activation, increase the level of HbF, inhibit Ca2+ 
channels, develop inhibitors for Psickle, Gardos channel and KCC, reduce the adhesion 
of RBCs and provide antioxidants. A new drugs called voxelotor, an aromatic aldehyde 
derivative, functions as an inhibitor of HbS polymerisation through increasing the 
oxygen affinity of HbS, and is currently in phase III trial (Vichinsky et al., 2019). Also, 
in 2017, the emergence of a new strategy of gene therapy has been utilised as well. 
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A 13 years old male patient showed positive results after transplanting him with 
autologous haematopoietic cells in which the cells were inserted with a lentiviral 
vector-mediated gene to replace HbS with normal Hb (an antisickling b-globin gene, 
bA(T87Q)) (Ribeil et al., 2017). 
However, gene therapy is not affordable due to the high medical cost of transfecting 
haematopoietic cells whilst SCD is most prevalent in some developing countries with 
relatively low economic resources. Hence, there is an urgent need to find cheaper 
treatment strategies for some SCA patients. Some physiological stimuli treatment and 
pharmacological treatments have been the focus of recent studies and have shown 

























1.8 Hypothesis and aims 
The three most significant abnormal features of red cells from SCA patients, which 
contribute in a major way to pathogenesis are: PS exposure increased by 
deoxygenation and sickling; HbS polymerisation and sickling; and increased cation 
permeability notably via the KCl cotransporter (KCC) with its aberrant response to 
oxygen level. A common link between all three are their reactions to oxygen tension 
and the deleterious effects of deoxygenation. 
This thesis will explore novel aspects of these three features with respect to their 
modulation by physiological stimuli experienced in vivo and a major pharmacological 
modulator, protein phosphorylation. 
 
1.8.1 Specific hypotheses 
1. Activation of HbS polymerisation and sickling; PS exposure; and KCC by key 
physiological stimuli and pharmacological modulators contributes significantly to the 
pathogenesis of SCD. 
2. A better understanding of the mechanisms involved will inform the development of 
novel therapeutic drugs. 
 
1.8.2 Specific aims 
Chapter Four: Investigation of key physiological and pharmacological stimuli / 
modulators which may alter HbS polymerisation and sickling. 
Chapter Five: Investigation of key physiological and pharmacological stimuli / 
modulators which may alter PS exposure. 
Chapter Six: Investigation of key physiological stimuli / modulators which may alter 
KCl cotransport. 
Chapter Seven: Investigation of key pharmacological stimuli / modulators which may 












2.1 Sheep red blood cells (RBCs) samples 
Adult sheep samples were purchased from TCS Biosciences Ltd. (Botolph Claydon, 
U.K.) and were stored at 4 °C in the refrigerator until needed. All experiments were 
carried out within 48 hours after blood collection. 
 
2.2 Human blood samples 
Human HbAA and HbSS blood sample were routinely collected by Professor David C. 
Rees from King’s College Hospital, which is with ethical permission (Reference 
Numbers: 11/LO/0065 and UI/EC/13/0077). Blood was stored in EDTA-containing 
vacutainers, stored at 4 °C in the refrigerator until needed. All experiments using blood 






















2.3 Chemicals and solutions: 
Table 2.1 List of chemicals and suppliers where they were purchased from. All chemicals were supplied 
by Sigma-Aldrich Chemical Co. (Poole, UK), unless otherwise stated. 
Name Supplier 
Radioisotope 
86Rb+ Perkin Elmer (Beaconsfield, UK) 
Inhibitors 
Bumetanide Calbiochem (Nottingham, UK) 
Ouabain  
Gas 
CO2 gas cylinder BOC Gases (Guildford, UK) 
N2 gas cylinder BOC Gases (Guildford, UK) 
O2 gas cylinder BOC Gases (Guildford, UK) 
Pharmacological reagents 
Calyculin A  
Cytochalasin B  
Ethylenediaminetetraacetic acid (EDTA)  
GsMTx-4 Abcam (Cambridge, UK) 
N-ethylmaleimide (NEM)  




3-(N-morpholino) propanesulfonic acid (MOPS)  
Br-A23187 ionophore  
Calcium chloride (CaCl2)  
Dibutyl phthalate (DBP) oil  
Dimethyl sulphoxide (DMSO)  
Drabkin’s reagent  
Glucose  
Glutaraldehyde  
Magnesium chloride (MgCl2)  
Methanol (³ 99.6%, laboratory used)  
Nitric acid (HNO3)  
Potassium chloride (KCl)  
Potassium ferricyanide (K3[Fe(CN6)] British Drug House (Poole, UK) 
Potassium nitrate (KNO3)  
Saponin  
Sodium chloride (NaCl)  
Sodium nitrate (NaNO3)  
Sodium hydroxide (NaOH)  
Sucrose  
TritonTM X-100  
Name Supplier 






All solutions utilised had an osmolality of 290 ± 5 mOsm·kg-1 unless otherwise stated. 
The pH of MOPS-buffered solutions was adjusted utilising the temperature of 
coefficient of MOPS !"#!$[°'] of -0.011 by addition of NaOH, HNO3 or Tris base (Good & 
Izawa, 1972). 
 
2.4.1 RBC wash solution 
To eliminate Cl- and prevent activation of the dehydration pathway, buffy coat RBCs 
were washed with MOPS-buffered solution (MBS-NO3 / N-MBS) *pH 7.4 at RT). 
145 mM  NaNO3 
10 mM  MOPS 
5 mM   Glucose 
 
MOPS-buffered solution (Cl-MBS) for RBC incubation. 
145 mM  NaCl 
10 mM  MOPS 
5 mM   Glucose 
 
Bicarbonate-buffered solution (BBS) for RBC incubation. 
121 mM  NaCl 
24 mM  NaHCO3 
10 mM  MOPS 
5 mM   Glucose 
 
2.4.2 O2 saturation solution 
0.6% w/v K3Fe(CN)6 
0.3% w/v saponin 
 
2.4.3 RBC morphology 
0.3% of glutaraldehyde in Cl-MBS, pH 7.4 at RT. 
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To examine medium composition effect on sickling (Chapter 4, section 4.2.6), 30% of 
methanol was utilised in Cl-MBS, BBS and plasma to fix RBCs, pH 7.4 at RT. 
 
2.4.4 Transport pathway measurement 
Stock solutions of bumetanide (10 mM), ouabain (10 mM) were made in Tris base and 
distilled water. When experiments were carried out utilising reagents dissolved in 
DMSO, controls also contained the same final percentage of solvent (< 0.5% final).  
 
(a) Tonometer incubation for influx measurement 
N-MBS, pH 7.4 at 37 °C. 
 
(b) Incubation media for influx measurement 
Cl-MBS, pH 7.4 / pH 7.0 /  
pH 6.5 at 37 °C 
BBS, pH 7.4 / pH 7.0 /  
pH 6.5 at 37 °C 
plasma, pH 7.4 / pH 
7.0 / pH 6.5 at 37°C 
145 mM NaCl 121 mM NaCl Autologous plasma 
10 mM MOPS 24 mM NaHCO3 100 μM Ouabain 
5 mM Glucose 10 mM MOPS 10 μM Bumetanide 
100 μM Ouabain 5 mM Glucose  
10 μM Bumetanide 100 μM Ouabain  
 10 μM Bumetanide  
 
     (c) Measurement of potassium chloride cotransport (KCC) after activation by 
physiological stimuli or pharmacological reagents 
Desired physiological stimuli / pharmacological reagents in N-MBS + ouabain + 
bumetanide 
Desired physiological stimuli / pharmacological reagents in Cl-MBS + ouabain + 
bumetanide 
 
     (d) 86Rb+ 






     (e) Mg-MBS wash solution, pH 7.4 at 4 °C 
An ice-cold isotonic MgCl2 solution (osmolality 290 ± 5 mOsm·kg-1) was utilised to 
eliminate unincorporated 86Rb+ 
107 mM MgCl2  10 mM MOPS 
 
2.5 Equipment 
§ Advanced Instruments Micro-Osmometer Model 3MO Plus, Advanced 
Instruments Inc., Fisher Scientific, Norwood, U.S. 
§ Balances: Sartorius, Basic BA61 and Sartorius MC210P, Bradford, MA, U.S. 
§ BD Vacutainer® test tubes, Becton Dickison, Plymouth, U.K. 
§ Centrifuge: type 541D, Eppendorf Ltd, U.K. 
§ Clark-type oxygen electrode and an oxygen meter CB1-D3, Hanstech, King’s 
Lynn, U.K. 
§ Disposable cuvettes (1.5 ml, 12.5x12.5x45 mm), GMBH + CO KG, Wertheim 
Germany. 
§ Double beam UC spectrometer, CE5501, Cecil Instruments, Cambridge, U.K. 
§ FisherbrandTM microhematocrit capillary tubes, Fisher Scientific U.K. Ltd., 
Loughborough, U.K. 
§ Fisherbrand™ Hemato-Seal™ Capillary Tube Sealant, Fisher Scientific U.K. Ltd., 
Loughborough, U.K. 
§ Flow cytometer BD AccuriTMC6, BD Accuri C6 Software, Becton Dickinson, 
Biosciences, San Jose, Ca U.S.A. 
§ Gas mixing pump: H. Wösthoff Messtechnik GmbH, Bochum, Germany 
§ GraphPad Prism version 6.0c, San Diego, CA, U.S. 
§ Hettich Hematocrit 210 Centrifuge, Andreas Hettich GmbH & Co., Tuttlingen 
Germany 
§ Kutofix c tonometers, Eschweiler, Kiel, Germany. 
§ Memmert oven, Memmert GmbH + Co. KG, Schwabach, Germany 
§ Leica DM6000B microscope, phase contrast, 20x/0.70 PH2 (HC PLAN APO) 
∞/0.17/C, equipped with a digital camera AF600DFC (magnification x1.6), 
Leica Microsystems Wetzlar GmbH, Milton Keynes, U.K. 
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§ Microsoft Office 2017 Excel version15.33, Washington, U.S. 
§ Micro haematocrit centrifuge haematospin 1400, Hawksley, Lancing, U.K. 
§ N2 cylinder, Surrey, England, U.K. 
§ O2 cylinder, Surrey, England, U.K. 
§ pH meter: SevenEasy and combination liquid filled electrodes, Mettler-Toledo 
AG, Analytical, Sonnenbergstrasse, Switzerland. 
§ Tri-carb liquid scintillation counter 2800TR, Perkin Elmer, Waltham, U.S. 
§ Water Bath: Grant, Grant Instruments (Cambridge) Ltd, Shepreth, 







































3.1 Sample collection and handling 
All sheep RBC samples were collected from LK sheep (~10 mM) (Evans, 1954), which 
have a high capacity of KCl cotransport. Before carrying out the experiment, the level 
of extracellular [K+] in LK sheep plasma were adjusted to 7.5 mM. Hence, it was 
important to measure intracellular [K+] and plasma [K+]. The [K+] in sheep RBCs and 
plasma were measured by The Queen's Veterinary School Hospital Central Diagnostic 
Services, and sheep plasma [K+] was then adjusted to 7.5 mM by addition of an 
appropriate volume of 100 mM KNO3. 
With regards to human HbSS RBCs, which were routinely collected by Professor David 
C. Rees from King’s College Hospital, their extracellular [K+] were adjusted to the 
same value (7.5 mM). The [K+] in HbAA / HbSS RBCs and plasma were measured by 
The Queen's Veterinary School Hospital Central Diagnostic Services, and HbAA / HbSS 
RBC’s plasma [K+] was then adjusted to 7.5 mM by addition of an appropriate volume 
of 100 mM KNO3. 
 
3.2 Testing the linearity of the gas mixing pump 
As a gas mixing pump was extensively utilised in all further experiments, it was 
important to examine its accuracy. This was carried out by measuring O2 tensions, 
utilising a Clark-type oxygen electrode linked with an oxygen meter CB1-D3. The gas 
mixing pump was set from 100% to 0% air. The gas mixture went through water into 





Figure 3.1 Linearity test of the H. Wösthoff Messtechnik gas mixer pump. The gas mixer was 
connected to the Clark-type electrode coupled to an oxygen meter CB1-D3 and then equilibrated with 
gas mixture for 10 min. Symbols represent the O2 tensions under different percentages of air, means 
± S.E.M., n= 3. 
 
3.3 Haematocrit determination 
To determine the volumetric proportion of RBCs in the suspensions, the measurement 
was determined by microhaematocrit centrifuge. FisherbrandTM microhaematocrit 
capillary tubes were filled with RBC suspensions (by capillary) and centrifuged for 5 
min at 13,000 x g utilising a Hawksley Haematospin 1400 Centrifuge. The ratio of RBC 
pellet to whole blood was determined utilising microhaemocrit reader. 
 
3.4 Measurement of water content of RBCs 
RBC water content was determined in triplicate and presented as ml water per g dry 
cell solids (ml.g-1 d.c.s.). RBC samples were firstly washed in N-MBS (pH 7.4 at room 
temperature) and packed by 600 x g centrifugations. Then, the supernatant was 
removed. Samples were placed in EP tubes. Each EP tube contained 90 μl – 120 μl 
RBC suspension (together with various drugs, as required, or solvent in controls). To 
induce the influx or efflux of solute from sheep RBCs, the EP tubes were then pre-
incubated at 37 °C for 45 min. Where necessary, RBCs sample were transferred to 
tonometer and incubated for 60 min at the required O2 tensions. To stop the solute 
fluxes, RBCs samples were aliquoted into three pre-chilled EP tubes kept on ice and 
subsequent procedures were all carried out at 4 °C. RBC suspensions were then 
transferred into capillary tubes and centrifuged for 15 min at 11,000 x g, to obtain 
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tightly packed RBC pellets. After that, empty foil squares were dried and weighed. The 
pelleted RBCs from the capillary tubes were expressed onto the foil squares and their 
wet weight were measured carefully. RBC pellets were then dried at a temperature of 
95 °C – 100 °C, for more than 18 hours, after which dry weights were taken. The 
water content in ml per g dry cell solids (ml.g-1 d.c.s) was calculated by the following 
equations: wet weight = (wet+foil) - foil; water/cell = (wet+foil) – (dry+foil); dry 
weight = (dry+foil) – foil; ml.g-1 d.c.s. = (water/cell)/ (dry weight). 
 
3.5 Measurement of intracellular pH 
The RBC suspensions were placed into a tonometer and equilibrated with required 
nitrogen/air/carbon dioxide gas mixture, which was saturated with humidified gas 
mixtures at 37 °C. RBC suspensions were incubated under the desired gas mixture 
composition, in a gently rotating tonometer for 15 min. To maintain equilibration with 
gases, RBC samples were then transferred into small EP tubes and span through DBP 
(dibutyl phthalate) oil at 600 x g for 3 minutes. The packed RBCs were frozen and 
thawed twice to ensure complete haemolysis. The pH values of the lysed solution were 
measured at 37 °C using a pH meter. 
 
3.6 Oxygen saturation curve 
Oxygen saturation curves (OSC) were determined at 37 °C. This method was achieved 
by placing RBC suspensions (50% Hct) in an Eschweiler tonometer in a water bath at 
37 °C. The tonometer was connected to the gas mixer and samples were equilibrated 
at the required O2 tension (0% or 100% air). 
An appropriate volume of 10 µl RBC suspensions were added to a saponin (0.3%) / 
ferricyanide (0.6%) solution in the Clark-type electrode using a Hamilton syringe. The 
saponin / ferricyanide solution was used to lyse the RBCs and displaced oxygen from 
haemoglobin. The initial and final readings were then recorded. The difference in 
readings made with RBCs equilibrated with 0 mmHg O2 and fully oxygenated (at 150 
mmHg O2) were used to obtain a volume for 100 % O2 saturation. O2 saturations were 
then measured at various time points (time points: 0 min, 6 min, 9 min, 12 min, 15 
min) to ascertain how quickly O2 equilibrations were achieved. 
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Herein, the Hb oxygen saturation in blood samples was investigated by determining 
two oxygen equilibrium curves at the same pH. To fully oxygenate or deoxygenate the 
sheep RBC samples, the samples (50% Hct) were equilibrated for up to 15 min at the 
required O2 tension before measuring Hb O2 saturation by utilising a Clark-type oxygen 
electrode and an oxygen meter CB1-D3. In the first experiment, the Hb O2 saturation 
was measured during re-oxygenation changing O2 tensions from 0% air (PO2= 0 
mmHg) to 100% air (PO2= 150 mmHg). Meanwhile, for comparison, the Hb 
deoxygenation rate RBCs from 100% air (PO2= 150 mmHg) to 0% air (PO2= 0 mmHg) 
was measured as well. 
In both cases, 50% change in O2 saturation was achieved after about 8 min. Re-
oxygenation was completed by 12 min, whilst de-oxygenation took relatively longer 
and was achieved after about 15 min. In subsequent experiments, equilibration with 
gases was taken over 15 min. 
 
 
Figure 3.2 Time course of the change in Hb oxygen saturation of RBCs. The solid line represents sheep 
RBCs re-oxygenated from 0% air to 100% air. The dashed line represents RBCs de-oxygenated from 
100% air to 0% air. The experiment utilised sheep RBCs but similar results were obtained with human 
RBCs. 
 
3.7 Measurement of RBC sickling 
RBCs were incubated in tonometers for 15 min at 37 °C at each oxygen tension and 
then fixed in N-MBS (0.2% haematocrit) containing 0.3% glutaraldehyde which would 
maintain RBC shape for several weeks (Milligan et al., 2013). The shape of RBC was 
studied under a Leica DM6000B light microscope. Elongated RBCs with egg-shape or 
pencil forms with spiky turns were counted as sickled. At least 500 RBCs were counted, 





3.8 Measurement of PS exposure in HbSS RBCs 
3.8.1 Lactadherin-FITC (fluorescein isothiocyanate) titration 
Lactadherin is a 45-kda glycoprotein milk fat globule-EGF factor 8, which is generated 
by macrophages and has an ability to bind to PS on apoptotic cells, promoting their 
clearance by macrophages (Hanayama et al., 2002; Albanyan et al., 2009; Zhou et al., 
2009). Another protein which is called Annexin V has been utilised to detect PS 
exposure in HbSS RBCs (Dasgupta et al., 2006; Albanyan et al., 2009). According to 
Albanyan el al.’s and Zhou et al’.’s study, it is Ca2+ dependent and requires a higher 
threshold of PS exposure (2% - 8%) in HbSS RBCs, which makes it less useful for the 
current set of experiments (Albanyan et al., 2009; Zhou et al., 2009). Comparing to 
annexin V, lactadherin has a higher sensitivity to detect PS exposure at lower level of 
PS exposure (0.5%) and binds independent of PE membrane and Ca2+ (Shi et al., 
2006; Waehrens et al., 2009; Zhou et al., 2009). Based on previous research, the 
optimum condition for labelling exposed PS on RBCs is to incubate at room 
temperature for 10 min (Weiss et al., 2011). In this study, each batch of LA-FITC 
titrated was to find out the minimal concentration required. RBCs were incubated in 
HK saline (100 μM [Ca2+]o) with 6 μM calcium ionophore Br-A23187 (0.5% Hct) for 30 
min at 37 °C. After that, 5 μl (about 105 RBCs) of the cell suspension was added to 
tubes containing 250 μl of HK saline (100 μM [Ca2+]o) with different concentrations of 
LA-FITC (0 - 32 nM) in duplicates, for fluorescence labelling of exposed PS. Labelling 
of PS was carried out at room temperature for 10 min in the dark. Detection of PS 
exposure increased with LA-FITC concentration (Figure 3.3). Although the cells were 
not fully saturated at 16 nM, it yielded a high enough detection signal for PS exposure 
with minimal effective concentration of LA-FITC. Hence, this concentration was utilised 





Figure 3.3 Optimization of LA-FITC binding to PS exposed on RBCs from SCA patients. After 30 min 
incubation at 37 °C with Br-A23187 (6 μM, 0.5 % Hct), RBCs were harvested and added to lactadherin-
binding saline with LA-FITC (100 μM [Ca2+]o HK saline). Lactadherin-labelling of PS exposing RBCs was 
carried out for 10 min in the dark at room temperature after which RBCs were washed once (600 x g 
for 3 min, followed by short spin; 16,000 x g for 10 s) and kept on ice until FACS analysis. Symbols 
represent a single experiment representative of 2 others. 
 
3.8.2 Calcium loading of RBCs with ionophore 
PS exposure was stimulated in RBCs by utilising a Ca2+ ionophore. After the proper 
washes in HK saline, to remove contaminant Ca2+, RBCs were washed once into LK or 
HK saline containing 2 mM EGTA. To alter intracellular calcium concentration ([Ca2+]i),  
RBCs (0.5 % Hct) were then incubated with Br-A23187 (dissolved in DMSO; final 
concentration of DMSO was 0.5%) and different [Ca2+]os clamped with 2 mM EGTA in 
LK or HK saline. To inhibit the plasma membrane Ca2+ pump (PMCA) and flippase 
during Ca2+ loading, vanadate (1 mM in aqueous solution) was also added to RBC 
solution. Ca2+ entry and stimulation of the Ca2+ pump would otherwise rapidly deplete 
ATP and could lead to secondary effects. Br-A23187 is non-fluorescent with an 
apparent transport selectivity for Ca2+ over Mg2+ (Debono et al., 1981). This 
transportation is electroneutral via diffusion through the membrane leading to an 
exchange of one Ca2+ for two H+, which slowly increases intracellular (about 0.1 
units/10 min) (Erdahl et al., 1995). Also, the extent of Ca2+ transport is dependent on 
the concentrations of Br-A23187. [Ca2+]i is fixed according to free [Ca2+]o and the 
Donnan equilibrium ratio (r) [Ca2+]i = [Ca2+]o x r2, where r2 equals 2.05 for the 






















membrane of RBCs from SCA patients (Flatman & Lew, 1977; Muzyamba et al., 2006). 
Results showed that the flux of Ca2+ with Br-A23187 stimulated maximal PS exposure 
in RBCs from SCA patients by 20 min incubation, therefore, incubation for all the 
experiments on Br-A23187 was carried out at 37 °C for 30 min (Figure 3.4a). 
The optimal concentration of Br-A23187 required to clamp [Ca2+]i reliably for PS 
exposure was nominally 2 - 6 μM (Figure 3.4). The [Mg2+]o in these experiments was 
usually 0.15 mM to keep [Mg2+]i at physiological levels. Due to the altered activity of 
different batches of ionophore Br-A23187 varied, each was titrated to set up the 
minimal concentration required to clamp [Ca2+]i. RBC suspensions were oxygenated 
at all times and incubated for 30 min in Eppendorf tubes (1.5 ml) in plastic racks which 
were immersed in water bath at 37 °C. Aliquots (5 μl, 105 RBCs) were labelled with 
LA- FITC and analysed by FACS (Figure 3.4b). 
 
 
Figure 3.4 Optimization of Ca2+ ionophore Br-A23187 in RBCs from SCA patients. RBCs (0.5% Hct) 
were first treated with vanadate (1 mM) to inhibit the plasma membrane Ca2+ pump (PMCA) and 
flippase before incubation for 30 min at 37 oC with Br-A23187. (a) Br-A23187 (6 μM) incubation time 
course in HK saline containing 100 μM [Ca2+]o, before labelling with LA-FITC (b) RBC suspension with 
Br-A23187 (nominally 0 - 6 μM) in HK saline containing 100 μM [Ca2+]o. Symbols represent a single 














































3.9 Time course of the pH change in BBS/plasma at different partial 
pressures of CO2  
The pH value of BBS and plasma was adjusted by altering the partial pressure of CO2. 
To explore the pH value change in BBS and plasma, BBS/plasma was gassed with 
desired O2/CO2/N2 gas composition at 37°C for up to 6 min. The pH value change in 
BBS/plasma was measured every minute. Results confirmed that the pH value of each 
buffer system gassed with desired gas composition became steady within 4 min. The 
pH values of BBS and plasma were calculated by utilising Henderson-Hasselbalch 
equation:	"# = "%& + lg	( [#)*+!],.,+∗/)*"), (“pKa = 6.1”, a negative logarithm of the acid 
dissociation constant for H2CO3, and “0.03*PCO2” was [H2CO3]). 
Figure 3.5 shows a plot of the pH value change in BBS during a 6 min incubation with 
different partial pressures of CO2 (PCO2= 7.13 mmHg, PCO2= 43 mmHg, PCO2= 100 
mmHg, PCO2= 321 mmHg). To obtain pH 7.4, pH 7.0 or pH 6.5 BBS, BBS needed to 
be incubated at 37°C and equilibration with appropriate partial pressures of CO2 for 
at least 4 min. 




Figure 3.5 Time course of the pH change in BBS altered by different partial pressures of CO2. BBS was 
gassed with desired gas composition and equilibrated in tonometer at 37°C for 6 minutes. (), PCO2= 
7.13 mmHg incubation; (p), PCO2= 43 mmHg incubation; (), PCO2= 100 mmHg incubation; (£), 







Figure 3.6 Time course of the pH change in plasma altered by different partial pressures of CO2. 
Plasma was gassed with desired gas composition and equilibrated in tonometer at 37°C for 6 minutes. 
(¯), PCO2= 7.13 mmHg incubation; (q), PCO2= 43 mmHg incubation; (È), PCO2= 100 mmHg 






















3.10 Control experiment – intracellular RBC [K+] and extracellular plasma 
[K+] in LK sheep and human HbSS RBCs 
Before carrying out the sheep flux experiments, the intracellular RBC [K+] and 
extracellular plasma [K+] of LK sheep, and that of plasma in human HbSS samples 
were measured (Table 3.1). Table 3.1 refers just to sheep samples but the same 
procedure was utilised to adjust the extracellular [K+] in HbSS plasma. 
At the beginning of each experiment, the extracellular plasma [K+] was adjusted to 
7.5 mM utilising a stock solution of 100 mM KNO3 as any variation in [K+] would affect 
K+ influx. Table 6.1 shows the results of intracellular RBC [K+] and extracellular plasma 
[K+] in different LK sheep. The mean value of intracellular RBC [K+] was 12.8 ± 1.6 
mM (mean ± S.E.M, n=11). The mean value of extracellular plasma [K+] was 4.2 ± 
0.2 mM (mean ± S.E.M, n=11). The results confirmed that all sheep utilised in this 
project were LK, in which the intracellular RBC [K+] was about 10 mM (Evans, 1954). 
 
Table 3.1 The intracellular RBC [K+] and extracellular plasma [K+] of sheep blood used in various 
experiments. 
Sheep 




1 15 4.4 
2 26 4.3 
3 7 4.4 
4 13 4.1 
5 13 4.5 
6 11 4.1 
7 8 4.1 
8 7 4.8 
9 15 5.1 
10 16 4.2 
11 10 2.6 
Mean 12.8 4.2 




3.11 Control experiment – water content of RBCs 
KCC activity can be altered by cell volume, therefore, it was important to check 
whether the RBC volume was changed by incubation in Cl-MBS, BBS and autologous 
plasma. Table 3.2 presents the water content in different sheep RBCs all at pH 7.4. 
Each measurement was carried out in triplicate. The mean value of RBC water content 
incubation with Cl-MBS was 1.97 ± 0.04 mgg-1 d.c.s (mean ± S.E.M, n=11). With 
regards to sheep RBCs incubation with BBS, the mean value of RBC water content was 
1.91 ± 0.04 mgg-1 d.c.s (mean ± S.E.M, n=11). With regards to the sheep RBCs 
incubation with plasma, the mean value of RBC water content was 1.95 ± 0.05 mgg-
1 d.c.s (mean ± S.E.M, n=11). Though the mean ± S.E.M value of water content in 
RBC in BBS was slightly lower than in Cl-MBS or in plasma, the results confirmed that 
incubation media did not have a significant effect on RBC volume. Similar results were 





















Table 3.2 The water content of RBCs after incubation with Cl-MBS, BBS and plasma at pH 7.4. Each 
determination was carried out in triplicate. No significant differences (n.s.) in volume were found after 
incubating in either Cl-MBS, BBS or plasma by Student’s t test. 
Sheep The water 














1 1.79 1.74 1.73 
2 2.25 2.07 2.18 
3 2.01 1.95 1.97 
4 1.95 2.11 2.07 
5 1.82 1.76 1.78 
6 2.01 1.95 1.90 
7 1.82 1.72 1.76 
8 2.05 1.93 1.98 
9 1.96 1.84 1.89 
10 2.01 1.95 2.08 
11 2.03 2.01 2.15 
Mean 1.97 1.91 1.95 
Mean ± S.E.M. 1.97 ± 0.04 (n.s.) 1.91 ± 0.04 (n.s.) 1.95 ± 0.05 (n.s.) 
 
3.12 Measurement of the K+ influx 
The permeability of several K+ pathways was measured by utilising radioisotope 86Rb+, 
which is a known K+ congener. 86Rb+ (final concentration (0.02-0.05 MBq/ml) was 
added to all tubes at a final [K+] of 7.5 mM. To remove unincorporated radioisotope 
86Rb+ in each tube and terminate fluxes, RBC suspensions were added into EP tubes, 
which contained ice-chilled MgCl2 saline. Then, RBC suspensions were centrifuged at 
600 x g for 10 seconds. The supernatants were then removed, and another aliquot of 
wash solution added. This washing cycle was repeated four more times. After the final 
wash, 0.5 ml of 0.01% Triton X-100 was added to lyse packed RBCs. To precipitate 
protein, 0.5 ml 5% trichloroacetic acid was added to EP tubes. The EP tubes were 
then centrifuged at 13,000 rpm for 5 minutes. The 86Rb+-containing supernatant was 
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analysed by Čerenkov radiation in a liquid scintillation counter. The K+ influxes were 
calculated as micromoles K+ per litre per hour by utilising the following equation: 
 
Herein, the term “cpm” represents counts per minute each tube. 




Data are presented either as individual results representative of at least 3 experiments 
on different individuals or as means ± S.E.M. in RBC samples from n different 
individuals. Statistical significance of paired variables was analysed by Student t-test 
or one-way ANOVA with Tukey (to compare paired values) or Dunnett’s (to compare 
to a control value) by utilising Graphpad Prism software (La Jolla, CA, USA). 
Correlations were tested utilising Pearson correlation test. A value of p < 0.05 was 
considered significant; calculations were made utilising Microsoft Office Excel or 


















4 HbS polymerisation and sickling 
 
4.0 Introduction 
Erythrocyte sickling and haemolysis due to HbS polymerisation upon deoxygenation is 
a hallmark morbidity in those patients with sickle cell anaemia (SCA). Accordingly, 
inhibition of HbS polymerisation is a vital non-genetic therapeutic approach to 
ameliorate the sequelae of sickle cell HbS polymerisation such as vaso-occlusive crises 
(VOCs) and acute chest syndrome (Pauling et al., 1949; Ingram, 1957; Marotta et al., 
1977). There are two major physiological characteristics which tend to induce HbS 
polymerisation and fibre formation: hypoxia and acidosis. Under a hypoxic 
environment, HbS molecules tend to aggregate, undergoing a homogeneous 
nucleation event by forming single fibres. This may be followed by a second 
polymerisation event, the heterogeneous nucleation, in which branches of new fibres 
are added to the surface of existing ones (Ferrone et al., 1980; Eaton & Hofrichter, 
1990). Moreover, in an acidotic environment, the low pH decreases the solubility of 
HbS which results in an increased driving force for HbS polymerisation, as observed 
in SCA patients (Ueda & Bookchin, 1984). In order to understand how key 
physiological factors affect HbSS RBC morphology, experiments were carried out to 
examine their effects on sickling in HbSS RBCs under three different oxygen tensions: 
150, 30 and 0 mmHg; to investigate the effect of rate of deoxygenation on sickling of 
HbSS RBCs; effect of different pHs on sickling; effect of urea at levels found in the 
renal medulla (in presence of 300 mM NaCl) and the effect of anisotonicity (i.e. cell 
volume). 
Over the past five decades, a number of anti-sickling drugs / therapeutics have been 
proposed including urea at high salt level (Mahmood, 1974), a dehydration manoeuvre 
(Brugnara, 2001) which has previously been suggested to prevent HbS fibres 
formation due to interference by urea with hydrophobic bonds responsible for the HbS 
polymerisation and by lowering the activity and concentration of intracellular HbS 
(Eaton, 2002). Moreover, five drugs were utilised to understand their pharmacological 
roles in sickling of HbSS RBCs, as they will be used in future chapters to examine their 
effect on one of the major dehydration pathways involved in pathogenesis, the KCl 
cotransporter or KCC (Chapters 6 and 7): staurosporine, a potent and non-selective 
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inhibitor of protein kinases which also induces cell apoptosis by an unknown 
mechanism; calyculin A, a potent phosphatase inhibitor for triggering red cell 
shrinkage and phospholipid scrambling of the erythrocyte cell membrane (Almasry et 
al., 2016); N-ethylmaleimide (NEM), a drug normally used for blocking cellular 
sulfhydryl groups in proteins and peptides; WNK463, the first orally bioavailable pan-
WNK-kinases inhibitor for inhibiting with-no-lysine kinases (WNKs). Overall, a better 
understanding of their pharmacological effects on HbSS RBC morphology could serve 
to elucidate the pathophysiology of SCD, may inform potential therapeutic approaches 
and also act as important control experiments for later work examining their effects 
on KCC activity. 
Whilst there is an extensive literature on HbSS sickling and conditions affecting HbS 
polymerisation, most experiments in this thesis are carried out using special Eschweiler 
tonometers to equilibrate RBC samples under the requisite conditions of oxygen, 
carbon dioxide and pH. It was therefore important to determine carefully the effects 
of these different conditions on sickling, using this particular apparatus, as they are 
important control experiments which are necessary for the interpretation of later 



















4.2 Effect of physiological stimuli on the morphology of HbSS RBCs  
4.2.1 Effect of different oxygen tensions (150, 30 and 0 mmHg) on sickling 
Oxygen tension (PO2) is one of the most important physiological parameters which 
affect sickling of HbSS RBCs. The polymerisation of sickle haemoglobin is an 
equilibrium between insoluble HbS crystals and dissolved HbS in solution. The kinetic 
features of HbS polymers formation underlie critical determinants of sickle RBCs 
morphology. Meanwhile, robust evidence suggest that sickle cell suspensions and HbS 
in solution are strongly dependent on PO2 (Winslow, 2006). In this study, HbSS RBCs 
sickling conditions were investigated under three oxygen tensions: 150, 30 and 0 
mmHg. 
At an oxygen tension of 150 mmHg, only biconcave HbSS RBCs were observed in RBCs 
solution, which implied HbSS RBCs were fully oxygenated (Figure 4.1). However, the 
proportion of elongated HbSS RBCs rose to approximately 60% and that of biconcave 
HbSS RBCs proportion decreased to about 40% when RBC aliquots were exposed to 
an oxygen tension of 30 mmHg. When HbSS RBCs were incubated at 0 mmHg oxygen 
tension, the proportion of elongated RBCs significantly increased to 80% and that of 
biconcave HbSS RBCs proportion fell to 20%, which implied that HbSS RBCs were 
significantly deoxygenated. Moreover, the proportion of elongated RBCs in 0 mmHg 








Figure 4.1 Effect of different oxygen tensions on sickling of HbSS RBCs. HbSS RBCs (1% Hct) were 
firstly equilibrated in Eschweiler tonometers for 15 min at the required oxygen tensions (150 mmHg, 
30 mmHg or 0 mmHg) in Cl-MBS. Experimental pH was pH 7.4 at 37 °C. Glutaraldehyde (0.3% as final 
concentration) was then added into the RBC aliquots which were then incubated for 10 min at the same 
oxygen tension before cell counting under light microscopy. In this figure, “B” represents biconcave 
HbSS RBCs and “E” represents elongated HbSS RBCs. Histograms represent means ± S.E.M. * p < 0.05 
(n=3). 
 
4.2.2 Effect of rate of deoxygenation on sickling 
Rotation of the tonometer is an important way to evenly mix the RBC suspensions and 
ensure that they are fully equilibrated at the desired oxygen tensions. In many SCA 
patients, individuals are suffering from vaso-occlusive crises, which in turn induce 
tissue ischemia and infarction. The consequences of vaso-occlusion are mainly caused 
by exposure of RBCs from high-velocity and high-oxygen levels, for example in 
cerebral arteries, to a sudden change to low-velocity and low-oxygen postcapillary 
venules. Rate of deoxygenation is also known to affect the balance between 
homogeneous and heterogeneous nucleation and hence RBC morphology, which may 
impact upon cell behaviour. Therefore, it is important to understand the effect of rate 
of deoxygenation on RBC morphology from SCD patients. In this work therefore, the 
effect of different rates of deoxygenation (adjusted by controlling rotation speed of 
tonometer) on sickling were compared. 
HbSS RBC suspensions (1% Hct, 0.5 ml) were first incubated in Cl-MBS for 15 min in 
Eschweiler tonometers at 37 °C, which were flushed with warm and humidified N2 or 
air at 5-10 bubbles.s-1 with different rotation speeds. To fix the RBC morphology, 






































10 min. The RBC suspensions were taken from the tonometers and transferred to 
Eppendorf tubes for cell counting. 
As shown in Figure 4.2, results indicated that no elongated RBCs were found in RBC 
suspensions at an oxygen tension of 150 mmHg, regardless of the rotation speed of 
the tonometers. However, at an oxygen tension of 0 mmHg, at high tonometer 
rotation speed (180 rpm), the number of elongated RBCs increased to 80% and the 
number of biconcave RBCs fell to 20%. While at a medium tonometer rotation speed 
of 100 rpm and at the slowest rotation speed of 80 rpm, the number of elongated 
RBCs increased to 75% and 60% at an oxygen tension of 0 mmHg. The number of 
biconcave RBCs fell to 25% at the medium rotation speed (100 rpm) and 35% at the 
slowest rotation speed (80 rpm) RBCs, all at an oxygen tension of 0 mmHg. 
Comparing the RBC morphology at 180 rpm (PO2=0 mmHg) with that at 100 rpm 
tonometer (PO2=0 mmHg), elongated RBC number was 6% (p < 0.05) higher than 
that at the 100 rpm rotation speed, whilst there were 33% more elongated RBC 
number at 180 rpm (p < 0.05) compared with those at 80 rpm, and 25% higher when 














Figure 4.2 Effect of rate of deoxygenation on sickling of HbSS RBCs. HbSS RBCs (1% Hct) were firstly 
equilibrated in Eschweiler tonometers for 15 min at O2 tensions of 150 mmHg and 0 mmHg. The rate 
of deoxygenation was controlled by adjusting the rotation speed of Eschweiler tonometers. In all of the 
experiments, the tonometers were flushed with the same gas bubble speed (5-10 bubbles.s-1). The 
aliquots were fixed as described in the legend to Figure 4.1. Herein, “rpm” represents “revolutions per 
minute”. “O” represents HbSS RBCs flushed with 150 mmHg O2, in which RBCs were fully oxygenated, 
“DO” represents HbSS RBCs flushed with 0 mmHg O2, in which RBCs were fully deoxygenated. “B” 
represents biconcave HbSS RBCs and “E” represents elongated HbSS RBCs. Histograms represent 
means ± S.E.M. * p < 0.05 (n=3). 
 
4.2.3 Effect of extracellular pH on sickling 
Extracellular pH is another key physiological parameter which determines the HbSS 
RBC morphology. The normal biconcave shape and deformability of human RBCs are 
important biological functions which allow RBCs to pass through small capillaries and 
transport oxygen and carbon dioxide throughout the microcirculation. In small blood 
vessels, RBCs alter their shape to squeeze through narrow parts of the circulation, and 
this ability is dependent on the non-covalent cytoskeleton of spectrin tetramers 
together with their attachments to the plasma membrane. However, in some SCA 
patients, sickle RBCs lose the ability to reverse their elastic deformation following 
passage through the blood microcirculation because of low surface to volume ratio 
and disruption to the cytoskeleton, leading to severe complications such as pulmonary 
hypertension (Pham et al., 2000; Diez-Silva et al., 2010). The renal medulla represents 
an area which poses particular challenges to HbSS RBCs, being both hypoxic and 
acidotic, which can induce morphology changes in HbSS RBCs, causing decreased 













































Diez-Silva et al., 2010). In this context, it is noticeable that around a third of SCA 
patients lack a functional renal medulla and the ability to concentrate their urine. 
The following experiment (Figure 4.3) was designed to investigate the effect of pH 
across a wide range from pH 6 to pH 8 on sickling of HbSS RBCs. Sickling markedly 
increased in pH 7.4, pH 7.0 and pH 6.5, from 8% (p < 0.05) to 38% (p < 0.05) to 
38% (p < 0.05), respectively, compared to that at pH 8 under 0 mmHg PO2 
environment. Sickling also significantly increased at pH 7.0 and at pH 6.5, which 
increased from 14% (p < 0.05) and 13% (p < 0.05), compared to the same number 
at pH 7.4. No significant change in sickling was observed as pH was decreased from 
pH 7.0 to pH 6.5 under a 0 mmHg PO2 environment. 
 
 
Figure 4.3 Effect of extracellular pH on sickling of HbSS RBCs. HbSS RBCs (1% Hct) were firstly 
equilibrated in Eschweiler tonometers in Cl-MBS (different pHs) for 15 min at O2 tensions of 150 mmHg 
and 0 mmHg. The aliquots were fixed as described in the legend to Figure 4.1. Herein, “O” represents 
HbSS RBCs flushed with 150 mmHg O2, in which RBCs were fully oxygenated, “DO” represents HbSS 
RBCs flushed with 0 mmHg O2, in which RBCs were fully deoxygenated. “B” represents biconcave HbSS 
RBCs and “E” represents elongated HbSS RBCs. Histograms represent means ± S.E.M. * p < 0.05 (n=3), 

































































4.2.4 Effect of urea at levels found in the renal medulla (600 mM) in 
combination with hypertonic concentrations of NaCl on sickling 
The sickling of HbSS RBCs was compared in the absence and presence of 600 mM 
urea in combination with 300 mM NaCl in Cl-MBS at oxygen tensions of 150 mmHg 
and 0 mmHg. These condition mimic those found physiologically in a healthy renal 
medulla during maximal antidiuresis. In Cl-MBS containing 600 mM urea and a total 
of 300 mM NaCl (PO2 = 150 mmHg), sickling percentage was 62.5% (p < 0.05) lower 
than that in the absence of urea and high NaCl at an oxygen tension of 0 mmHg. 
 
 
Figure 4.4 Effect of urea at concentrations found in the renal medulla (600 mM) in combination with 
hypertonic NaCl (300 mM NaCl). HbSS RBCs (1% Hct) were firstly equilibrated in Eschweiler tonometers 
in Cl-MBS for 15 min at O2 tensions of 150 mmHg and 0 mmHg. The aliquots were fixed as described 
in the legend to Figure 4.1. Herein, “-U” represents HbSS RBCs incubated with Cl-MBS in the absence 
of urea and 300 mM NaCl; “+U” represents HbSS RBCs incubated with Cl-MBS in the presence of urea 
and 300 mM NaCl. “O” represents HbSS RBCs flushed with 150 mmHg O2, in which RBCs were fully 
oxygenated, “DO” represents HbSS RBCs flushed with 0 mmHg O2, in which RBCs were fully 
deoxygenated. “B” represents biconcave HbSS RBCs and “E” represents elongated HbSS RBCs. 
Histograms represent means ± S.E.M. * p < 0.05 (n=4), n.s. indicates “not significant” by Student’s t 
test. 
 
4.2.5 Effect of hypotonic swelling on sickling 
In this experiment, the effect of hypotonic swelling on sickling of RBCs was 
investigated. In all cases, osmolality, pH, extracellular [K+] and O2 tension were all 
carefully controlled. The osmolality of the basic Cl-MBS was altered by addition of 
water by up to 30%, either reducing it or raising it. Under these conditions, RBC water 
content was found to change by about 25% (Carden et al., 2017). In Figure 4.5, the 
sickling percentage in RBCs swollen by 10%, 20% and 30%, decreased by 62% (p < 
0.05), by 87% (p < 0.05) and by 97% (p < 0.05), compared to those RBCs at normal 
cell volume, respectively. Also, the sickling percentage in 20% swollen RBCs and 30% 























swollen RBCs were 67% (p < 0.05) and 93% (p < 0.05) less than those which was 
10% swollen RBCs at an oxygen tension of 0 mmHg. Moreover, sickling percentage in 
30% swollen RBCs was 80% (p < 0.05) less than that in those swollen by 20%. 
 
 
Figure 4.5 Effect of hypotonic swelling (i.e. cell volume) on sickling of RBCs. HbSS RBCs (1% Hct) 
were firstly equilibrated in Eschweiler tonometers in Cl-MBS for 15 min at O2 tensions of 150 mmHg 
and 0 mmHg. RBC volume was altered anisotonically through addition of water (so that the incubati0on 
media were made hypotonic by 10%, 20% and 30%) in Cl-MBS. The aliquots were fixed as described 
in the legend to Figure 4.1. “SW” represents HbSS RBCs were placed in Cl-MBS with addition of water 
and thereby swollen by 10%, 20% and 30%. “O” represents HbSS RBCs flushed with 150 mmHg O2, 
in which RBCs were fully oxygenated, “DO” represents HbSS RBCs flushed with 0 mmHg O2, in which 
RBCs were fully deoxygenated. “B” represents biconcave HbSS RBCs and “E” represents elongated 
HbSS RBCs. Histograms represent means ± S.E.M. * p < 0.05 (n=4). 
 
4.2.6 Effect of buffer (Cl-MBS, BBS and autologous plasma) on sickling 
RBC morphology was examined in Cl-MBS and compared to that in cells incubated in 
bicarbonate-buffered saline (BBS) and autologous plasma. Due to the fact that protein 
crosslinking on exposure to glutaraldehyde cause plasma to form a gel-like mixture, 
which caused RBC haemolysis and prevented analysis of RBC morphology, an 
alternative method of fixing the cells to avoid this problem was first established. It 
was found that methanol represented a good fixative which did not react in a 
deleterious way with plasma proteins. 
In this case, RBCs were incubated with chilled and different methanol concentrations 
(using a stock of ³ 99.6%, laboratory grade) for 10 min after carrying out the 



































































experiments established the concentration and incubation time required to fix RBCs 
using methanol supplemented to Cl-MBS. Figure 4.6.1 (a) shows the survival rate of 
RBCs after 10 min incubation with different concentrations of methanol in Cl-MBS. 
Survival rate was found to be nearly 100% after incubation with 0% - 30% methanol 
(v/v%) in Cl-MBS at O2 tensions of 150 mmHg and 0 mmHg. When the methanol / Cl-
MBS volume ratio was increased to 40% (v/v%), RBCs started to undergo haemolysis 
and survival rates fell to less than 10%. All RBCs underwent haemolysis at a methanol 
concentration of 50% (v/v%), at O2 tensions of 150 mmHg and 0 mmHg. In Figure 
4.6.1 (b), sickling percentage was highest at 20% when the RBCs were fixed with 
30% ratio of methanol at O2 tensions of 0 mmHg compared to those fixed with 10% 
methanol (sickling percentage: 5%) and 20% methanol (sickling percentage: 8%) at 
an O2 tension of 0 mmHg. 
 
 
Figure 4.6.1 Effect of methanol on fixation of HbSS RBCs. HbSS RBCs (1% Hct) were first equilibrated 
in Eschweiler tonometers for 15 min at O2 tensions of 150 mmHg and 0 mmHg. Different volumes of 
chilled methanol were then added into aliquots which were then incubated for 10 min before cell 
counting under microscope. Methanol were placed on ice and bubbled with desired O2 tensions before 
utilising. Figure (a) represents the survival rate of HbSS RBCs under different volume combination of 
chilled methanol / Cl-MBS. Figure (b) represents sickling percentage of RBCs founded in aliquots after 
10 min incubation with desired methanol concentration. “O” represents HbSS RBCs were flushed with 
150 mmHg O2, in which RBCs were fully oxygenated, “DO” represents HbSS RBCs were flushed with 0 
mmHg O2, in which RBCs were fully deoxygenated. Histograms represent a single experiment 
representative of 2 others. 
 
To examine whether 30% methanol (v/v%) could adequately fix RBCs in all three 
media (Cl-MBS, BBS and plasma), methanol was added to RBC aliquots which had 
been fully oxygenated or deoxygenated for 15 min at O2 tensions of 150 mmHg and 
0 mmHg. Figure 4.6.2 shows that there was no significant change in sickling 
percentage comparing RBCs incubated in the three buffers at either O2 tension. The 













































result suggested that RBCs in Cl-MBS and BBS presented the same sickling percentage 
in 30% methanol as they do in 0.3% glutaraldehyde. Hence, 30% chilled methanol 
was used for cell fixation in subsequent experiments in this section. 
 
 
Figure 4.6.2 Effect of RBC fixation by 30% methanol (v/v%) in Cl-MBS, BBS and plasma. HbSS RBCs 
(1% Hct) were firstly equilibrated in Eschweiler tonometers for 15 min at O2 tensions of 150 mmHg 
and 0 mmHg. Methanol was placed on ice and bubbled with desired O2 tensions. Chilled methanol (30 
v/v%) was then added into RBC aliquots which were then incubated for a further 10 min before cell 
counting. Methanol aliquots were placed on ice and bubbled with desired O2 tensions before utilising. 
Experimental pH was pH 7.4, adjusted using HNO3 in Cl-MBS, but with PCO2 = 43 mmHg in the case 
of BBS and plasma. After addition of methanol, RBC suspensions were then flushed with 150 mmHg or 
0 mmHg O2. “O” represents HbSS RBCs flushed with 150 mmHg air, in which RBCs were fully 
oxygenated, “DO” represents flushed with 150 mmHg N2, in which RBCs were fully deoxygenated. 
Histograms represent a single experiment representative of 2 others. 
 
After establishing an appropriate protocol for fixation of RBCs using methanol, the 
effect of medium composition of Cl-MBS, BBS and plasma on RBC sickling was then 
investigated. RBC aliquots were incubated at oxygen tensions of 150 mmHg and 0 
mmHg at pH 7.4. In Figure 4.6.3, RBC sickling was 6% (p < 0.05) and 8% (p < 0.05) 
less when RBC aliquots were incubated with BBS and plasma, compared to that in Cl-
MBS. There was no significant change between HbSS RBCs incubated with BBS and 



























Figure 4.6.3 Effect of buffer (Cl-MBS, BBS and plasma) on sickling of HbSS RBCs. HbSS RBCs (1% 
Hct) were firstly equilibrated in Eschweiler tonometers in Cl-MBS, BBS and plasma for 15 min at O2 
tensions of 150 mmHg and 0 mmHg. Experimental pH was pH 7.4, adjusted using HNO3 in MBS, but 
with PCO2 = 43 mmHg in the case of BBS and plasma. The aliquots were fixed by 30% chilled methanol 
as described in the legend to Figure 4.6.2. “O” represents HbSS RBCs flushed with 150 mmHg O2, in 
which RBCs were fully oxygenated, “DO” represents HbSS RBCs flushed with 0 mmHg O2, in which 
RBCs were fully deoxygenated. “B” represents biconcave HbSS RBCs and “E” represents elongated 
HbSS RBCs. Histograms represent means ± S.E.M. * p < 0.05 (n=3), n.s. indicates “not significant” by 
Student’s t test. 
 
4.3 Effect of lactic acid and low pH on sickling of HbSS RBCs 
Acidosis is well known as a promoter of HbS polymerisation, however, only a few 
studies report acid / base disorders in SCA patients (Petto et al., 2011). The 
commonest cause of physiological acidosis is anaerobic metabolism in skeletal muscle 
beds with glycolysis producing high levels of lactic acid. The membrane of RBCs is 
known to express monocarboxylate transporters which will enable lactic acid or lactate 
to gain access to their cytoplasm. Notwithstanding, the effect of acidosis induced by 
lactic acid has not been hitherto investigated on HbS polymerisation and RBC shape 
change. In this series of experiments, therefore, the sickling of HbSS RBCs was 
investigated in the absence / presence of lactic acid (10 mM) over a wide range of 
pHs (pH 7.4, pH 7.0, pH 6.5 and pH 6.0) in Cl-MBS. In Figure 4.7 (a), in the absence 
/ presence of lactic acid, no sickling percentage was observed in HbSS RBCs at an 
oxygen tension of 150 mmHg. 
At an oxygen tension of 0 mmHg (Figure 4.7 (b)), in the presence 10 mM lactic acid, 

















































7.4 Cl-MBS, 60% (p < 0.05) at pH 7.0 Cl-MBS, 47% (p < 0.05) at pH 6.5 Cl-MBS and 
32% (p < 0.05) at pH 6.0 Cl-MBS, compared to that in the absence of lactic acid, 
showing that lactic acid resulted in greater morphological change. 
 
 
Figure 4.7 Effect of lactic acid and a range of extracellular pH on sickling of HbSS RBCs. HbSS RBCs 
(1% Hct) were firstly equilibrated in Eschweiler tonometers in Cl-MBS at different extracellular pHs in 
the absence / presence of 10 mM lactic acid (Figure 4.7 (a) and Figure 4.7 (b)) for 15 min at O2 tensions 
of 150 mmHg and 0 mmHg, respectively. The aliquots were fixed as described in the legend to Figure 
4.1. Herein, “-lac” represents HbSS RBCs were incubated in Cl-MBS in the absence of lactic acid; “+lac” 
represents HbSS RBCs were incubated in Cl-MBS in the presence of 10 mM lactic acid; “O” represents 
HbSS RBCs flushed with 150 mmHg O2, in which RBCs were fully oxygenated, “DO” represents HbSS 
RBCs flushed with 0 mmHg O2, in which RBCs were fully deoxygenated. “B” represents biconcave HbSS 
RBCs and “E” represents elongated HbSS RBCs. Histograms represent means ± S.E.M. * p < 0.05 (n=3), 
n.s. indicates “not significant” by Student’s t test. 
 
4.4 Effect of incubation time and extracellular pH on sickling 
Sickling of HbSS RBCs was investigated following incubation for different durations (0, 
20 and 40 min) in pH 7.0 Cl-MBS at 37 °C. 
There was no sickling apparent at 150 mmHg oxygen among duration of incubation 
(0, 20 or 40 min) (Figure 4.8). At 0 mmHg oxygen, at pH 7, sickling percentages were 
markedly increased after 20 min and 40 min, being 87% (p < 0.05) and 88% (p < 























































































































































Figure 4.8 Effect of duration of incubation on sickling of HbSS RBCs at different extracellular pHs. 
HbSS RBCs (1% Hct) were firstly equilibrated in Eschweiler tonometers in Cl-MBS (pH 7.0) for 0, 20 
and 40 min at O2 tensions of 150 mmHg and 0 mmHg. The aliquots were fixed accordingly at desired 
time course as described in the legend to Figure 4.1. Herein, “O” represents HbSS RBCs flushed with 
150 mmHg O2, in which RBCs were fully oxygenated; “DO” represents HbSS RBCs flushed with 0 mmHg 
O2, in which RBCs were fully deoxygenated. “B” represents biconcave HbSS RBCs and “E” represents 
elongated HbSS RBCs. Histograms represent means ± S.E.M. * p < 0.05 (n=3), n.s. indicates “not 














































































4.5 Effect of modulation of protein phosphorylation by staurosporine, 
calyculin A, NEM and WNK463 on sickling  
In subsequent work (chapter 7), the effect of pharmacological reagents which 
modulate protein phosphorylation were investigated to determine their effects on KCC 
activity (Chapters 6 and 7). It was therefore important to ascertain whether or not 
these compounds altered RBC morphology, which on its own may modify KCC activity. 
 
4.5.1 Effect of staurosporine on sickling 
The effect of staurosporine on sickling of HbSS RBCs was first investigated at pH 7.4 
in Cl-MBS. There was no significant change in the presence of 100 µM staurosporine 
at pH 7.4 Cl-MBS, compared to that in its absence (Figure 4.9). 
 
 
Figure 4.9 Effect of staurosporine on sickling of HbSS RBCs. HbSS RBCs (1% Hct) were firstly 
equilibrated in Eschweiler tonometers in the absence /presence of 100 µM staurosporine for 15 min at 
O2 tensions of 150 mmHg and 0 mmHg. The aliquots were fixed as described in the legend to Figure 
4.1. Herein, “O” represents HbSS RBCs were flushed with 150 mmHg O2, in which RBCs were fully 
oxygenated, “DO” represents HbSS RBCs were flushed with 0 mmHg O2, in which RBCs were fully 
deoxygenated. “B” represents biconcave HbSS RBCs and “E” represents elongated HbSS RBCs. 












































4.5.2 Effect of calyculin A on sickling 
The sickling of RBCs was investigated in the presence / absence of 100 nM calyculin 
A in pH 7.4 Cl-MBS at 37 °C. There was no significant change in the presence of 100 
nM calyculin A at pH 7.4 Cl-MBS, compared to that in its absence (Figure 4.10). 
 
 
Figure 4.10 Effect of calyculin A on sickling of RBCs. HbSS RBCs (1% Hct) were firstly equilibrated in 
Eschweiler tonometers in the absence /presence of 100 nM calyculin A for 15 min at O2 tensions of 150 
mmHg and 0 mmHg. The aliquots were fixed as described in the legend to Figure 4.1. Herein, “O” 
represents HbSS RBCs were flushed with 150 mmHg O2, in which RBCs were fully oxygenated, “DO” 
represents HbSS RBCs were flushed with 0 mmHg O2, in which RBCs were fully deoxygenated. “B” 
represents biconcave HbSS RBCs and “E” represents elongated HbSS RBCs. Histograms represent 



















































4.5.3 Effect of NEM on sickling 
The sickling of RBCs was investigated in the presence / absence of 1 mM NEM in pH 
7.4 Cl-MBS at 37 °C. There was no significant change in the presence of 1 mM NEM 
at pH 7.4 Cl-MBS, compared to that in its absence (Figure 4.11). 
 
 
Figure 4.11 Effect of NEM on sickling of RBCs. HbSS RBCs (1% Hct) were firstly equilibrated in 
Eschweiler tonometers in the absence /presence of 1 mM NEM for 15 min at O2 tensions of 150 mmHg 
and 0 mmHg. The aliquots were fixed as described in the legend to Figure 4.1. Herein, “O” represents 
HbSS RBCs were flushed with 150 mmHg O2, in which RBCs were fully oxygenated, “DO” represents 
HbSS RBCs were flushed with 0 mmHg O2, in which RBCs were fully deoxygenated. “B” represents 
biconcave HbSS RBCs and “E” represents elongated HbSS RBCs. Histograms represent means ± S.E.M. 



















































4.5.4 Effect of WNK463 on sickling 
The sickling of RBCs was investigated in the presence / absence of 40 nM WNK463 in 
pH 7.4 Cl-MBS at 37 °C. There was no significant change in the presence of 40 nM 
WNK463 at pH 7.4 Cl-MBS, compared to that in its absence (Figure 4.12). 
 
 
Figure 4.12 Effect of WNK463 on sickling of RBCs. HbSS RBCs (1% Hct) were firstly equilibrated in 
Eschweiler tonometers in the absence /presence of 40 nM WNK463 for 15 min at O2 tensions of 150 
mmHg and 0 mmHg. The aliquots were fixed as described in the legend to Figure 4.1. Herein, “O” 
represents HbSS RBCs were flushed with 150 mmHg O2, in which RBCs were fully oxygenated, “DO” 
represents HbSS RBCs were flushed with 0 mmHg O2, in which RBCs were fully deoxygenated. “B” 
represents biconcave HbSS RBCs and “E” represents elongated HbSS RBCs. Histograms represent 

























































4.6 Effect of cytochalasin B on sickling 
The sickling of HbSS RBCs was investigated in the presence / absence of 10 µM 
cytochalasin B in pH 7.4 Cl-MBS at 37 °C. There was no significant change in the 




Figure 4.13 Effect of cytochalasin B on sickling of RBCs. HbSS RBCs (1% Hct) were firstly equilibrated 
in Eschweiler tonometers in the absence /presence of 10 µM cytochalasin B for 15 min at O2 tensions 
of 150 mmHg and 0 mmHg. The aliquots were fixed as described in the legend to Figure 4.1. Herein, 
“O” represents HbSS RBCs were flushed with 150 mmHg O2, in which RBCs were fully oxygenated, “DO” 
represents HbSS RBCs were flushed with 0 mmHg O2, in which RBCs were fully deoxygenated. “B” 
represents biconcave HbSS RBCs and “E” represents elongated HbSS RBCs. Histograms represent 

























































4.7.1 Effect of physiological factors on sickling 
The ability to deform repeatedly is an important physiological feature of RBCs as they 
pass through the microvasculature and splenic sinusoids, and it is generally agreed 
that lack of this ability leads to vascular occlusion and disruption of tissue oxygenation. 
In SCA patients, combination of RBC sickling and RBC adherence to the endothelium 
leads to various SCD complications such as acute chest syndrome, avascular necrosis 
and organ damage. However, there is more than one physiological factor causing 
polymerisation of HbS and inducing sickling of HbSS RBCs. 
The rheologic properties of HbSS RBCs are influenced by various physiological factors 
such as oxygen tension, rate of deoxygenation, pH, urea, cell volume (surface to 
volume ratio, S/V ratio), buffer, lactic acid and low pH. This study re-emphasises the 
importance of these key physiological parameters which initiates sickling, together 
with possible methods for inhibition. 
Previous studies of the rheologic properties of HbSS RBCs have focused on the 
function of oxygen tension (Nash et al., 1986; Lu et al., 2016) and rate of 
deoxygenation (Kaul & Xue, 1991; Rab et al., 2019). The results summarised in Table 
4.1 involving oxygen tension and rate of deoxygenation display trends similar to those 
reported in these previous studies (Roselli & Fatt, 1980; Du et al., 2015; Rab et al., 
2019), notwithstanding the different conditions used, notably the use of Eschweiler 
tonometers. Sickling percentage of HbSS RBCs is deoxygenation-dependent, and 
increased greatly as oxygen tension was decreased. Results also suggest that sickling 
percentage of HbSS RBCs increases as rate of deoxygenation increases. Herein, the 
results in Table 4.1 support the relationship that sickling of aerated HbSS red cells in 
Cl-MBS depended upon Hb desaturation due to lowered oxygen tension and rate of 
deoxygenation - conditions which are commonly seen in athletes with SCD or at high 
altitude or in aeroplanes (Green et al., 1971; Schmied & Borjesson, 2014). Findings 
are also probably relevant to individuals with sickle cell trait (HbAS) who are largely 
ignored in the literature. 
The effect of altered extracellular pH on RBC sickling was also studied. The primary 
cause of sickling appears to be low pH and deoxygenation (Table 4.1). Results were 
consistent with the situations in a previous study (Lange et al., 1951; Bookchin et al., 
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1976; Ueda & Bookchin, 1984). Herein, possible counterparts of results in Table 4.1 
are seen in alkalosis and metabolic acidosis, whose possible mechanisms are mediated 
via low pH which could induce polymerisation of HbS and also enhance Psickle activity 
in deoxygenated HbSS RBCs (Joiner et al., 1993) and hence encourage dehydration. 
The effect of urea on sickling of HbSS RBCs, at concentrations found in the renal 
medulla during maximal antidiuresis, was also investigated. In Table 4.1, the result 
suggests that sickling percentage of HbSS RBCs decreases when urea concentration 
was increased under hypoxia. Possible mechanisms are that urea could have a weak-
interaction with proteins by some other mechanisms (Makhatadze & Privalov, 1992), 
further stabilising soluble HbS and preventing sickling of HbSS RBCs. 
The effect of hypotonicity on sickling of HbSS RBC was studied as well. In Table 4.1, 
it is summarised that sickling of HbSS RBC decreases when HbSS RBC volume 
increased. Possible mechanism is that increased cell volume will decrease intracellular 
[HbS] and further prevent red cell water loss and the efflux of K+ (Bunn et al., 1982; 
Fabry et al., 1982; Eaton & Hofrichter, 1987). 
The effect of incubation media, notably buffer composition, on sickling of HbSS RBCs 
were also studied in this chapter. In Table 4.1, the results suggest that BBS and 
plasma have a modest inhibitory effect on sickling of HbSS RBCs, compared to that in 
Cl-MBS. This might be due to that some of the composition of solutes in BBS and 
plasma - presumably the presence of bicarbonate or CO2 in both – which may create 
an environment for preventing macromolecular crowding. The high activity of the RBC 
anion exchanger will enable rapid entry of bicarbonate to the cell interior. 
The effect of lactic acid on sickling of HbSS RBCs was the final physiological parameter 
investigated. In a healthy human body, much of the lactate produced is buffered in 
the kidneys, heart muscle and mainly accumulated in the liver, active tissues and 
bloodstream. Especially in the heart muscle and liver tissue, two lactate molecules are 
transformed into glucose. In SCA patients, the baseline level of lactate is higher than 
normal values, leading to acute or chronic hepatic impairment and kidney dysfunction, 
which is thought to have a correlation between the accumulation of lactate in 
bloodstream and the hepatic lactate metabolism (Shao & Orringer, 1995; Banerjee et 
al., 2001). In Table 4.1, sickling of HbSS RBCs was shown to increase after addition 
of 10 mM lactic acid, which suggests that sickling of HbSS RBCs not only correlates to 
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pH value, but also is dependent on the level of lactic acid. As for bicarbonate, the RBC 
monocarboxylate transporter will allow lactate to enter the cytoplasm where it may 
modulate HbS polymerisation in the opposite manner, promoting polymer formation. 
Overall these findings indicate that several physiological parameters may alter HbS 
polymerisation and be significant in vivo although they are rarely considered (Gladwin 
& Sachdev, 2012; Merlet et al., 2019). 
 
Table 4.1 Effect of physiological stimuli on sickling 
Physiological stimuli Sickling 
PO2 PO2 ¯, sickling ­ 
Rate of deoxygenation Rate ­, sickling ­ 
pH pH ¯, sickling ­ 
Urea Sickling ¯ 
Anisotonicity Cell volume ­, sickling ¯ 
Medium composition Compared to Cl-MBS, sickling ¯ in BBS and 
plasma 
Duration of incubation When PO2 ¯ and time ­, then sickling ­ 
Lactic acid Sickling ­ 
 
4.7.2 Effect of pharmacological reagents on sickling 
Herein, five pharmacotherapeutic reagents (staurosporine, calyculin A, NEM, WNK463 
and cytochalasin B) were used to investigate their effects on sickling of HbSS RBCs, 
as they are important tools for the study of KCC activity (see Chapter 7). 
Staurosporine is normally used as a broad-spectrum protein kinase inhibitor and has 
been shown previously to stimulate KCC activity in HbSS RBCs. Calyculin A is an 
inhibitor on phosphatase activity, which reduces KCC activity (Almasry et al., 2016). 
NEM is a pharmacological reagent which mainly stimulate K-Cl cotransporters (KCCs) 
in human erythrocytes, probably via inhibition of regulatory protein kinases (Bize et 
al., 2000).  
With regards to WNK463, the result summarised in Table 4.2 suggests that sickling of 
HbSS RBCs did not change after addition of WNK463. WNK463 is a pan-WNK inhibitor, 
which increase KCC activity by inhibiting WNK in WNK/SPAK/OSR1 pathway in HbSS 
RBCs (Lu et al., 2019). 
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In Table 4.2, the summary of results shows that sickling of HbSS was unaffected by 
incubation with any of these reagents. 
Overall, the action of these reagents on sickling imply that their effect on 
morphological shape of sickle cells need not be considered when examining their 
effects on KCC activity. 
Finally, cytochalasin B is known to bind to actin filaments (Theodoropoulos et al., 1994) 
and also inhibits the binding of G-actin to the cytoplasmic face of RBC membranes 
(Gokhin et al., 2015). Also, it acts as an inhibitor of gas transporters such as hexose 
transport (Ebstensen & Plagemann, 1972) and some other actions relevant to RBC 
permeability and various signalling pathways including regulating protein kinase 
activity (Pedersen et al., 2001). Though its site of action remains unclear, it did not 
alter sickling of HbSS RBCs (Table 4.2). 
 
Table 4.2 Effect of pharmacological reagents on sickling 
Pharmacological 
reagents 
Sickling Actions of the drugs 
Staurosporine n.s. A protein kinase inhibitor, activate KCC in HbSS RBCs 
Calyculin A n.s. A phosphatase inhibitor, activate KCC in HbSS RBCs 
NEM n.s. A regulator protein kinase inhibitor, activate KCC in HbSS RBCs 
WNK463 n.s. A pan-WNK inhibitor, inhibit WNK andactivate KCC in HbSS RBCs 
Cytochalasin B n.s. An inhibitor of the binding of G-actin to RBC membrane; an 
inhibitor of sugar transporters; altering some other protein kinases 
which regulates RBC permeability 













5 Deoxygenation-induced phosphatidylserine exposure 
 
5.0 Introduction 
The externalisation of plasma membrane aminophospholipid phosphatidylserine (PS) 
in RBCs is a hallmark in those patients suffering from sickle cell anaemia, and occurs 
at a high level (~2-11%), compared to that in healthy individuals (<1% PS) (Wood et 
al., 1996; De Jong et al., 2001). The externalisation of PS in HbSS RBCs is believed to 
induce haemolysis and vaso-occlusion, and may be recognised by macrophages 
leading to the removal of RBC from the circulation. Although the mechanism of 
inducing PS exposure in HbSS RBCs remains unclear, deoxygenation-induced sickling 
(Lubin et al., 1981) and an increased concentration of intracellular Ca2+ (Bitbol et al., 
1989; Weiss et al., 2011) have been suggested to play an important role in SCA 
pathogenesis. 
According to Lubin et al., the level of PS in HbSS RBCs can be further increased / 
decreased by deoxygenation / reoxygenation in vitro (Lubin et al., 1981), which 
suggests red cell shape change by HbS polymerisation and sickling might be involved. 
Also, the involvement of Ca2+ was postulated, and was investigated from the 1980s 
onwards. However, less attention has been directed towards investigating the role of 
other physiological stimuli and potential pharmacological modulators. These factors 
represent the focus of the present chapter. 
Investigation of the PS exposure mechanism is complicated work by the numerous 
stimuli involved, including various cell signalling pathways leading to apoptosis (Boas 
et al., 1998), HbS instability and oxidative challenge (Obrador et al., 2015) and 
inactivation of the ATP-dependent flippase or PMCA by decreased ATP levels or those 
of intracellular Mg2+ (Bitbol et al., 1987; Etzion et al., 1993). Moreover, the rate of 
deoxygenation alters the shape of HbSS RBCs; slow HbS polymerisation results in 
elongated RBCs, medium in holly leaf-like shapes and fast polymerisation results in 
granular RBCs (Mozzarelli et al., 1987) and might alter the extent of activation of Psickle 
and hence of the entry of Ca2+ (Lew et al., 1997). Moreover, PS exposure can also be 
increased by HbSS RBC shrinkage following  activation of the Gardos channel by 
elevated intracellular Ca2+ ([Ca2+]i) (Lang et al., 2003a). 
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In this chapter, some of the relevant physiological stimuli which affect PS exposure in 
HbSS RBCs, such as the deoxygenation rate, pH, urea (in combination with hypertonic 
NaCl) and incubation media / buffers, were examined. Moreover, pharmacological 
manoeuvres such as Ca2+ removal and reagents such as GsMTx-4 and ruthenium red 
































5.2 Loading of Ca2+ on PS scrambling in HbSS RBCs 
In this experiment, the effect of different [Ca2+]os (0, 0.1, 0.3, 0.6, 1 and 10 μM) on 
the percentage of RBCs exposing PS in HK saline was carried out in RBCs treated with 
the ionophore Br-A23187. PS scrambling rose markedly with the increase in [Ca2+]os 
from 0 to 10 μM Ca2+ (Figure 5.1), in agreement with previous work carried out in this 
laboratory (Weiss et al., 2011; Cytlak et al., 2013). In Figure 5.1, compared to the 
percentage PS exposure in low micromolar [Ca2+]os (0 - 1 μM), the PS scrambling 
percentage was 10-fold greater in high micromolar [Ca2+]os (10 μM). 
 
 
Figure 5.1 Loading of Ca2+ on PS scrambling in HbSS RBCs. RBCs (0.5% Hct) were first treated with 
vanadate (1 mM) to inhibit the flippase and also the plasma membrane Ca2+ pump. Incubation was 
carried out in HK saline with the addition of Br-A23187 (6 µM) and EGTA/Ca2+ mixtures for 3 min at 
37 °C. RBCs aliquots were added to lactadherin – labelling solution (HK saline containing 16 nM LA-
FITC). Labelling of PS exposing RBCs was carried out for 10 min in the dark at room temperature after 
which RBCs were rinsed once (600 x g for 3 min, followed by a short spin at 16,000 g for 10 s), labelled 


























5.3 Effect of deoxygenation rate on PS scrambling in HbSS RBCs 
In Figure 5.2, the effect of deoxygenation rate (adjusted by controlling rotation speed 
of Eschweiler tonometer) on PS scrambling in HbSS RBCs was investigated. RBCs were 
incubated in Cl-MBS at pH 7.4. No significant PS exposure was present at the start of 
the experiment (time 0 min). Percentage PS exposure at a tonometer rotation speed 
of 180 rpm was markedly higher than at rotation speeds of 100 rpm and 80 rpm by 
46% (p < 0.05) and 1130%, respectively, after a 40 min incubation. 
 
 
Figure 5.2 Effect of deoxygenation rate on PS scrambling in HbSS RBCs. RBCs (0.5% Hct) were first 
treated with vanadate (1 mM) to inhibit the plasma membrane Ca2+ pump and the flippase. Incubation 
was carried out in Cl-MBS for 0, 20 and 40 min at 37 °C with different rotation speeds - 180 rpm, 100 
rpm and 80 rpm – at 0 mmHg O2, supplemented with N2. Lactadherin-labelling of PS exposing RBCs 
was carried out for 10 min in the dark at room temperature after which RBCs were washed (600 x g 
for 3 min, followed by a short spin at 16,000 x g for 10 s), labelled with LA-FITC and kept on ice until 










































5.4 Effect of pH on PS scrambling in HbSS RBCs 
In this experiment, the effect of pH on PS scrambling in HbSS RBCs was investigated. 
In Figure 5.3, no significant percentage PS exposure in HbSS RBCs was found at either 
pH 8.0, pH 7.4 or pH 6.0 Cl-MBS at the start of incubation in Cl-MBS (0 min). At pH 
7.4, percentage of PS exposure increased with time after 60 min incubation, which 
increased by 39% compared to that at the start of incubation (0 min). 
Moreover, percentage PS exposure of HbSS RBCs was 60% (p < 0.05) higher in pH 
7.4 Cl-MBS at oxygen tension of 0 mmHg compared to that in pH 8.0 Cl-MBS after 60 
min incubation. Percentage PS exposure of HbSS RBCs incubated with pH 7.4 Cl-MBS 
was 58% (p < 0.05) lower than that in pH 6.0 Cl-MBS after 60 min incubation. 
 
 
Figure 5.3 Effect of pH on PS scrambling in deoxygenated HbSS RBCs. RBCs (0.5% Hct) were 
incubated at 37 °C for 60 min at pH 8.0, pH 7.4 or pH 6.0 in Cl-MBS, which contained with 1 mM 
vanadate and 1.1 mM Ca2+. The same FACS analysis procedure as described in Figure 5.2 was then 
followed. Histograms represent means ± S.E.M. * p < 0.05 (n=3), n.s. indicates “not significant” by 













































5.5 Effect of urea on PS scrambling in HbSS RBCs 
Effect of urea on PS scrambling in HbSS RBCs incubated at pH 7.4 in Cl-MBS was 
investigated. In Figure 5.4, PS exposure at the start of the incubation was low, < 5%. 
In the absence of urea, PS exposure increased progressively with duration of 
deoxygenation reaching a value of about 40 % after 80 min. However, no significant 
percentage PS exposure was observed among HbSS RBCs incubated with added urea 
at any of the concentrations tested (200, 600 or 1200 mM). 
 
 
Figure 5.4 Effect of urea on PS scrambling in deoxygenated HbSS RBCs. RBCs (0.5% Hct) were 
incubated at 37 °C for 60 min in pH 7.4 Cl-MBS, which contained with 1 mM vanadate and 1.1 mM 
Ca2+. The same FACS analysis procedure as described in Figure 5.2 was then followed. Histograms 
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5.6 Effect of urea, hypertonicity and extracellular pH on PS scrambling in 
HbSS RBCs 
Effect of urea on PS scrambling in deoxygenated HbSS RBCs incubated at different 
extracellular pHs was investigated. In Figure 5.5, percentage PS exposure in HbSS 
RBCs incubated at pH 8.0 in Cl-MBS containing 600 mM urea and 300 mM NaCl was 
89% (p < 0.05) lower than that in the absence of urea and isotonic (145 mM) NaCl 
at 0 min. There was no significant change of percentage PS exposure in HbSS RBCs 
incubated with pH 8.0 Cl-MBS in the presence / absence of 600 mM urea and 300 mM 
NaCl over an 80 min time course. 
 
 
Figure 5.5 Effect of urea on PS scrambling in deoxygenated HbSS RBCs incubated at pH 8.0 in Cl-MBS. 
RBCs (0.5% Hct) were incubated at 37 °C for 80 min in pH 8.0, Cl-MBS, in the presence / absence of 
600 mM urea and 300 mM NaCl. The same procedure as described in Figure 5.2 was then followed. 
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In Figure 5.6, effect of urea on PS scrambling in HbSS RBCs incubated at pH 7.4 in 
Cl-MBS, in the presence / absence of urea and NaCl, was investigated. Percentage PS 
exposure in HbSS RBCs at pH 7.4 in Cl-MBS containing 600 mM urea and 300 mM 
NaCl was 76% (p < 0.05) lower than that in the absence of urea and NaCl at 0 min. 
Also, percentage PS exposure in HbSS RBCs, incubated in pH 7.4 Cl-MBS containing 
600 mM urea and 300 mM NaCl, was 88% (p < 0.05) lower than that in the absence 
of urea and in isotonic NaCl after 80 min incubation. 
 
 
Figure 5.6 Effect of urea on PS scrambling in deoxygenated HbSS RBCs incubated at pH 7.4 in Cl-MBS. 
RBCs (0.5% Hct) were incubated at 37 °C for 80 min in pH 7.4, Cl-MBS, which was in the presence / 
absence of 600 mM urea and 300 mM NaCl. The same procedure as described in Figure 5.2 was then 
followed. Histograms represent means ± S.E.M. * p < 0.05 (n=3). 
 
In Figure 5.7, effect of urea on PS scrambling in HbSS RBCs incubated in pH 7.0 Cl-
MBS, in the presence / absence of urea and NaCl, was investigated. Percentage PS 
exposure in HbSS RBCs, incubated at pH 7.0 in Cl-MBS containing 600 mM urea and 
300 mM NaCl, was 84% (p < 0.05) lower than that in the absence of urea and NaCl 
at 0 min. Also, percentage PS exposure in HbSS RBCs, incubated at pH 7.0 in Cl-MBS 
containing 600 mM urea and 300 mM NaCl, was 95% (p < 0.05) lower than that in 
the absence of urea and NaCl after 80 min incubation. 
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Figure 5.7 Effect of urea on PS scrambling in deoxygenated HbSS RBCs incubated at pH 7.0 in Cl-MBS. 
RBCs (0.5% Hct) were incubated at 37 °C for 80 min at pH 7.0 in Cl-MBS, which was in the presence / 
absence of 600 mM urea and 300 mM NaCl. The same procedure as described in Figure 5.2 was then 
followed. Histograms represent means ± S.E.M. * p < 0.05 (n=3). 
 
In Figure 5.8, effect of urea on PS scrambling in HbSS RBCs incubated at pH 6.0 in 
Cl-MBS, in the presence / absence of urea and NaCl, was investigated. Percentage PS 
exposure in HbSS RBCs, incubated at pH 6.0 in Cl-MBS containing 600 mM urea and 
300 mM NaCl, was 93% (p < 0.05) lower than that in the absence of urea and NaCl 
at 0 min. Also, percentage PS exposure in HbSS RBCs, incubated at pH 6.0 in Cl-MBS 
containing 600 mM urea and 300 mM NaCl, was 96% (p < 0.05) lower than that in 
the absence of urea and NaCl after 80 min incubation. 
 
 
Figure 5.8 Effect of urea on PS scrambling in deoxygenated HbSS RBCs incubated at pH 6.0 in Cl-MBS. 
RBCs (0.5% Hct) were incubated at 37 °C for 80 min at pH 6.0 in Cl-MBS, which was in the presence / 
absence of 600 mM urea and 300 mM NaCl. The same procedure as described in Figure 5.2 was then 
followed. Histograms represent means ± S.E.M. * p < 0.05 (n=3). 
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In Figure 5.9, effect of urea on PS scrambling in HbSS RBCs incubate at pH 8.0, pH 
7.4, pH 7.0 and pH 6.0, in the absence of urea and NaCl, were compared. There was 
no significant difference of percentage of PS exposure in HbSS RBCs incubated with 
pH 8.0, pH 7.4, pH 7.0 and pH 6.0 Cl-MBS in the absence of 600 mM urea and 300 
mM NaCl at 0 min. 
 
Figure 5.9 Effect of pH on PS scrambling in deoxygenated HbSS RBCs incubated at pH 8.0, pH 7.4, 
pH 7.0 and pH 6.0 Cl-MBS. RBCs (0.5% Hct) were incubated at 37 °C for 80 min in pH 8.0, pH 7.4, pH 
7.0 and pH 6.0, Cl-MBS, in the absence of 600 mM urea and 300 mM NaCl. The same procedure as 
described in Figure 5.2 was then followed. Histograms represent means ± S.E.M. * p < 0.05 (n=3), 
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5.7 Effect of incubation media on PS scrambling in HbSS RBCs 
In Figure 5.10, the effect of buffer on PS scrambling in deoxygenated HbSS RBCs was 
investigated.  PS exposure at time zero was 8 % and was the same in all three buffers.  
PS exposure then increased progressively in Cl-MBS reaching 33 % after 80 min. At 
all time points (20 - 80 min), PS exposure was reduced in BBS and plasma compared 
to that in Cl-MBS, with reductions of 43%, 47%, 52% and 51% (BBS), reductions of 
43%, 50%, 47% and 47% (plasma), after 20, 40, 60 and 80 min incubation, 
respectively. There was no significant difference in PS exposure between RBCs 
incubated in BBS or plasma. 
 
 
Figure 5.10 Effect of buffer on PS scrambling in deoxygenated HbSS RBCs. The same procedure as 
described in Figure 5.2 was followed but HbSS RBCs were incubated in three different incubation media: 
Cl-MBS, BBS and plasma. Herein, pH value of Cl-MBS was adjusted by utilising HNO3. However, to 
achieve pH 7.4 in BBS/plasma, these media were gassed with the appropriate partial pressure of CO2 
(PO2=100 mmHg/PN2=570 mmHg/PCO2=43 mmHg) at 37 °C. Histograms represent means ± S.E.M. * 













































5.8 Effect of extracellular [K+] on PS scrambling in HbSS RBCs 
In this experiment, the effect of extracellular [K+] on PS scrambling in deoxygenated 
HbSS RBCs was investigated. Again, PS exposure increased progressively with time 
from 12 % at time zero reaching about 38 % after 80 min. There was no significant 
change in percentage PS exposure when HbSS RBCs were incubated at high 
extracellular [K+] (100 mM [K+]) Cl-MBS compared to that at low extracellular [K+] 





Figure 5.11 Effect of extracellular [K+] on PS scrambling in deoxygenated HbSS RBCs. RBCs (0.5% 
Hct) were incubated at 37 °C for 80 min at pH 7.4 in Cl-MBS, which contained 7.5 mM [K+] (LK, low 
extracellular [K+] in Cl-MBS) or 100 mM [K+] (HK, high extracellular [K+] in Cl-MBS). The same 
procedure as described in Figure 5.2 was then followed. Histograms represent means ± S.E.M. n.s. 






































5.9 Effect of extracellular Ca2+ on PS scrambling in HbSS RBCs 
The effect of extracellular Ca2+ on PS scrambling in deoxygenated HbSS RBCs was 
investigated. In Figure 5.12, there was no significant difference in percentage PS 
exposure in HbSS RBCs incubated with Cl-MBS in the absence / presence of Ca2+, 
using either Cl-MBS containing 1.1 mM Ca2+ or Ca2+-free Cl-MBS containing 1 mM 
EDTA) at 0 min, with levels of 12% in both conditions. With time, PS exposure 
increased to 42% in the presence of Ca2+ but only 22% in its absence. When Ca2+ 
was absent, PS exposure was reduced by 35%, 34%, 29% and 27% after 20, 40, 60 
and 80 min, respectively. 
 
 
Figure 5.12 Effect of extracellular Ca2+ on PS scrambling in deoxygenated HbSS RBCs. RBCs (0.5% 
Hct) were incubated at 37 °C for 80 min at pH 7.4 in Cl-MBS, in the presence of Ca2+ (1.1 mM) or its 
absence (0 Ca2+ plus 1 mM EDTA). The same procedure as described in Figure 5.2 was then followed. 
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5.10 Effect of GsMTx-4 on PS scrambling in HbSS RBCs 
In this experiment, GsMTx-4, an inhibitor of Piezo1, was utilised to examine its effect 
on PS scrambling in HbSS RBCs, as Piezo1 is a candidate protein for the Psickle 
conductance pathway activated by sickling. In Figure 5.13, deoxygenation again 
caused a time-dependent increase in PS exposure, reaching 17% after 80 min. At all 
time points, increased PS exposure was observed in deoxygenated Cl-MBS containing 
10 μM GsMTx-4. GsMTx4 (10 μM) significantly increased percentage PS exposure by 
106% after 80 min incubation. This finding was contrary to that expected. 
 
 
Figure 5.13 Effect of GsMTx-4 on PS scrambling in deoxygenated HbSS RBCs. RBCs (0.5% Hct) were 
incubated at 37 °C for 80 min at pH 7.4 in Cl-MBS, in the absence / presence of 10 μM GsMTx-4. The 
same procedure as described in Figure 5.2 was then followed. Histograms represent means ± S.E.M. * 







































5.11 Effect of ruthenium red on PS scrambling in HbSS RBCs 
Because of the unexpected stimulatory effect of GsMTx-4 on PS exposure, in this 
experiment, the effect of ruthenium red was investigated.  Ruthenium red is known 
to block both Piezo1 and Piezo2 (Coste et al., 2010) as well as a number of TRPV 
channels which have also been postulated to be present in the RBC membrane – 
although it is a somewhat promiscuous reagent with other non-specific effects.  
Findings were similar to those observed with GsMTx-4. Increased PS exposure was 
observed in RBCs deoxygenated in Cl-MBS containing 30 μM ruthenium red. In the 
presence of ruthenium red, PS exposure was increased from 18% to 32% in 
deoxygenated RBCs after 80 min incubation. 
 
 
Figure 5.14 Effect of ruthenium red on PS scrambling in deoxygenated HbSS RBCs. RBCs (0.5% Hct) 
were incubated at 37 °C for 80 min at pH 7.4 in Cl-MBS, in the absence / presence of 30 μM ruthenium 
red. The same procedure as described in Figure 5.2 was then followed. Histograms represent means ± 






































The present findings further define the effects of various physiological stimuli and 
pharmacological agents on PS exposure in HbSS RBCs. PS exposure was found in 
various physiological conditions to which RBCs from SCA patients are likely to be 
exposed (Wood et al., 1996; De Jong et al., 2001; Dasgupta & Thiagarajan, 2005; 
Cytlak et al., 2013) and which may therefore play a role in pathogenesis. Particularly, 
effects of some key physiological stimuli were examined such as deoxygenation rate, 
pH, urea (with high [NaCl]) and incubation media. Also, three typical pharmacological 
reagents, EDTA, GsMTx-4 and ruthenium red, were examined for their effects on PS 
exposure in HbSS RBCs. 
 
5.12.1 Effect of physiological stimuli on PS scrambling in HbSS RBCs 
Table 5.1 shows effects of some key physiological stimuli on PS scrambling in HbSS 
RBCs. In this study, PS scrambling in HbSS RBCs increased when the deoxygenation 
rate increased. Deoxygenation alone is well recognised to elicit PS exposure (Lubin et 
al., 1981; Blumenfeld et al., 1991). The current findings show rate of deoxygenation 
is also important.  The exact mechanism of this requires further investigation, however, 
faster deoxygenation rate is known to cause increased morphological changes in sickle 
cells (chapter 4).  It is possible that a more marked distortion of the membrane will 
cause greater activation of Psickle and hence Ca2+ entry. Other possibilities include 
increased ceramide production which is also known to follow RBC distortion, notably 
shrinkage, and which is implicated in PS exposure (Lang et al., 2003b). It was 
noticeable that in all experiments sickling was already maximal after 20 min 
deoxygenation, whilst significant PS exposure required at least 20 – 40 min. The 
reason of causing this delay might be that deoxygenation-induced process of 
accumulating sufficient [Ca2+]i to reach the threshold for PS scrambling may be 
relatively slow, particularly in comparison with Ca2+ loading using an ionophore such 
as A23187 (Bitbol et al., 1987; Williamson et al., 1992; Kamp et al., 2001). 
Table 5.1 also shows the effect of pH on PS exposure in HbSS RBCs. The result 
indicates that PS scrambling increases as pH decreases over the range of pH 8.0 to 
pH 6.0. It is likely pH will fall to these low values in active muscle beds and in the 
renal medulla, hence contributing to vaso-occlusive crises which are associated with 
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exercise and with sickle nephropathy in which necrosis of the renal medulla is a 
common complication of the disease. Interestingly, although hypertonicity due to high 
urea levels - whether alone or in combination with high salt levels - reduced PS levels. 
This suggests that in a fully functioning kidney, urea may ameliorate the deleterious 
effects of the peculiar conditions found in the medulla during antidiuresis, at least in 
sickle patients. It is intriguing to speculate that the same dehydration protection effect 
will be found in RBCs from normal individuals. High urea levels, therefore, may have 
a dual role: their known effect to boost the countercurrent multiplier to maximise 
medullary hypertonicity for water conservation, but a second role in protecting RBCs 
as they traverse the vasa recta.  In sickle nephropathy, as the renal medulla necroses 
and fibroses and becomes non-functional, this second protective effect of urea will be 
lost. 
Finally, in the context of the relatively slow time course for PS exposure noted above, 
the low flow rates, extreme conditions and increased stickiness of sickle RBCs all 
potentially act synergistically to result in medullary infarction. 
The effect of incubation media on PS exposure in HbSS RBCs is also summarised in 
Table 5.1. PS scrambling in HbSS RBCs was reduced in BBS and plasma, in comparison 
to that in Cl-MBS. In this context, it has been reported that a component of plasma, 
likely bicarbonate or CO2, reduces KCC activity in RBCs relative to that observed in 
artificial saline (Godart et al., 1997). The mechanism and significance of the present 
findings extend our appreciation of how RBCs behave in vivo and warrant further 
investigation. 
Lastly, the effect of extracellular [K+] on PS exposure in HbSS RBCs was examined. 
There was no difference in PS exposure in HbSS RBCs in HK Cl-MBS or LK Cl-MBS 
although previously some inhibition has been observed in HK media (Weiss et al., 









Table 5.1 Effect of physiological stimuli on PS scrambling in SCA patients. 
Physiological stimuli Phosphatidylserine exposure 
Deoxygenation rate Rate ­, PS ­ 
pH pH ¯, PS ­ 
Urea PS ¯ 
Urea, in combination with NaCl PS ¯ 
Incubation media Compared to Cl-MBS, PS ¯ in BBS and plasma 
Extracellular [K+] NC* 
*Not changed. 
 
5.12.2 Effect of pharmacological reagents on PS scrambling in HbSS RBCs 
Table 5.2 summarises the effects of three pharmacological reagents on PS scrambling 
in HbSS RBCs. 
EDTA is normally utilised as an anticoagulant reagent in blood samples meant for 
routine laboratory analysis (Kafka & Yermiahu, 1998). The rationale of anticoagulant 
is based on inhibiting the aggregation of platelet and various reaction of the 
haemostatic cascade by chelating free Ca2+ ions. In addition to its anticoagulant effect, 
the present result (Table 5.2) also show that EDTA has a marked inhibitory effect on 
PS exposure in HbSS RBCs, compared to those incubated in an extracellular [Ca2+] of 
1.1 mM. This has been observed previously (Weiss et al., 2012; Cytlak et al., 2013) 
and an obvious mechanism is the absence of entry of Ca2+ through the Psickle pathway 
whose identity may be Piezo1 or possibly a TRPV channel. Accordingly, experiments 
were carried out with GsMTx-4, a spider venom neuropeptide which can inhibit cationic 
mechanosensitive channels (MSCs) including Piezo1 (Suchyna, 2017) and with 
ruthenium red which inhibits certain TRPV channels. Unexpectedly, results 
summarised in Table 5.2 show that both reagents actually increased PS exposure. It 
is difficult to reconcile these findings. However, GsMTx-4 is a difficult reagent and 
effects varies with batch. It also functions to distort cell membranes so whilst it may 
act as a Piezo1 inhibitor (Bae et al., 2011), this action may be masked by membrane 
distortion rather increasing activity. Ruthenium red is also non-specific and it has been 
observed previously that it causes RBC clumping (Malécot et al., 1998), which may 




Table 5.2 Effect of pharmacological reagents on PS scrambling in SCA patients. 
Pharmacological reagents Phosphatidylserine exposure 
EDTA ¯ 
GsMTx-4 ­ 































6 KCl cotransporter and physiological modulators 
 
6.0 Introduction 
KCCs are expressed in a large variety of cells such as RBCs, tumour cells and 
hepatocytes, and have the potential to mediate regulatory volume decrease (RVD) 
following cell swelling (Lauf et al., 1992; Shen et al., 2003).  
In sickle RBCs, abnormal KCC activation can induce the loss of intracellular potassium 
and chloride with water following osmotically via other channels (aquaporins), leading 
to RBC shrinkage, [HbS] elevation and HbS polymerisation acceleration, which in turn 
induce the red cells to sickle (Quarmyne et al., 2011). In SCD patients, the details of 
KCC activation are complex and remain unclear, with various possible stimuli including 
the Mg2+ depletion (Jennings & Al-Rohil, 1990). Pharmacological evidence and 
molecular biology indicate that KCC is regulated by protein phosphorylation/ 
dephosphorylation, via cascades of regulatory protein kinases and phosphatases such 
as protein kinases Syk and Src or phosphatases PP1 and PP2A (Bize et al., 2000). 
Overall, KCC activation has been concluded a net dehydration event, which is 
associated with solute loss and water dehydration. 
Suspension in autologous plasma has previously been shown to inhibit markedly the 
activity of the KCC in RBCs from patients with SCD (Godart et al., 1997).The cause 
appeared to be the presence of HCO3- / CO2 buffer system (i.e. bicarbonate-buffered 
saline, BBS), when compared to artificial buffers such as MBS (MOPS-buffered saline), 
rather than some other component of plasma. Their finding prompted the authors of 
this earlier report to ask the question “Do HbSS erythrocytes lose KCl in physiological 
conditions?”, thereby questioning the importance of KCC activity in mediating solute 
loss and dehydration of sickle cells. 
The work of Godart et al., however, only investigated the effect of plasma on RBCs 
swollen by dilution of their incubation solution with water. In vivo, such anisotonic 
swelling of red cells is an unlikely occurrence. The main physiological stimuli for KCC, 
urea (as concentrated in the renal medulla) or low pH (as encountered in active muscle 
beds) and Mg2+ depletion, were not tested. A key difference between anisotonic 
swelling as a stimulus, and those provided by low pH or urea, is their effect on ionic 
strength and [Cl-] - with a reduction of both by addition of water but not by the other 
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two modalities. In many cells, change in [Cl-] has profound effects on cell behaviour 
including on volume regulatory systems such as KCC (Voets et al., 1999). Furthermore, 
in RBCs from another species with physiologically high levels of KCl cotransport, 
namely horses, neither suspension in plasma nor BBS had any effect on KCC activity 
when using swelling or low pH as stimuli (Speake et al., 1997). Urea was not tested 
although it is known to stimulate KCC activity in equine red cells (Speake et al., 1997). 
These factors prompted a re-evaluation of the effect of plasma on RBC KCC activity. 
In this chapter, a third model species in which red cell KCC activity has been much 
studied, sheep, was also utilised for comparison with HbSS RBCs: first, because HbSS 
RBCs appear to differ to findings with horse; and, second, because volume of plasma 
is a major limiting factor in these experiments due to the low volume of samples 
available from SCD patients whilst it is much easier to obtain large samples from sheep. 
The hypothesis underlying the work is that swelling-stimulation of KCC in sickle cells 
is not representative of the effect of plasma on KCC activity more generally, so 
questioning the assertion of Godart et al. and re-emphasising a central importance of 





























6.2 Effect of external pH on oxygen-dependent KCl cotransport in HbSS 
RBCs 
In this experiment, effect of external pH on oxygen-dependent KCl cotransport in HbSS 
RBCs was investigated in different incubation media: Cl-MBS, BBS and autologous 
plasma. As shown in Figure 6.1 (a), K+ influxes were significantly greater in pH 7.0 
incubation media, compared with pH 7.4 incubation media in PO2 = 677 mmHg. 
Comparing K+ influxes in pH 7.4 incubation media with pH 7.0 incubation media in 
PO2 = 677 mmHg, K+ influxes were relatively increased by about 35% (p≤0.05) in Cl-
MBS; 69% (p≤0.05) in BBS and 93% (p≤0.05) in plasma. 
In Figure 6.1 (b), K+ influxes were also significantly greater in pH 7.0 incubation media, 
compared with pH 7.4 incubation media in PO2 = 100 mmHg. Comparing K+ influxes 
in pH 7.4 incubation media with pH 7.0 incubation media in PO2 = 677 mmHg, K+ 
influxes were relatively increased by about 24% (p≤0.05) in Cl-MBS; 70% (p≤0.05) 
in BBS and 125% (p≤0.05) in plasma. 
 
 
Figure 6.1 Effect of external pH on oxygen-dependent KCl cotransport in HbSS RBCs. HbSS RBCs 
(50% Hct) were equilibrated in Eschweiler tonometer for 15 min at desired oxygen tension (677 mmHg 
or 100 mmHg). (a) was incubated in PO2 = 677 mmHg; (b) was incubated in PO2 = 100 mmHg. 
Experimental incubation media pHs were pH 7.4 or pH 7.0, adjusted by utilising HNO3 in MBS, but were 
gassed with PO2=677 (100) mmHg/PCO2=43 mmHg to obtain either pH 7.4 BBS or pH 7.4 plasma; 
PO2=677 (100) mmHg/PCO2=100 mmHg to obtain either pH 7.0 BBS or pH 7.0 plasma. RBC aliquots 
were then diluted 10-fold into test tubes pre-equilibrated with the same gas mixtures for measurement 
of K+ influx (extracellular [K+] of 7.5 mM) over 10 min. All influxes were carried out in the presence of 
ouabain (100 µM) and bumetanide (10 µM) to inhibit K+ influx through the Na+/K+ pump and NKCC, 
































































































6.3 Effect of urea on oxygen-dependent KCl cotransport in HbSS RBCs 
In this experiment, the effect of urea on oxygen-dependent KCl cotransport in HbSS 
RBCs was investigated in different incubation media: Cl-MBS, BBS and autologous 
plasma. As shown in Figure 6.2 (a), K+ influxes were significantly greater in incubation 
media in the presence of 750 mM urea, compared with incubation media in the 
absence of urea in PO2 = 677 mmHg. Comparing K+ influxes in incubation media in 
the presence of urea with incubation media in the absence of urea in PO2 = 677 mmHg, 
K+ influxes were relatively increased by about 59% (p≤0.05) in Cl-MBS; 50% (p≤0.05) 
in BBS and 25% (p≤0.05) in plasma. 
In Figure 6.2 (b), K+ influxes were significantly greater in incubation media in the 
presence of 750 mM urea, compared with incubation media in the absence of urea in 
PO2 = 100 mmHg. Comparing K+ influxes in incubation media in the presence of urea 
with incubation media in the absence of urea in PO2 = 100 mmHg, K+ influxes were 
relatively increased by about 92% (p≤0.05) in Cl-MBS; 71% (p≤0.05) in BBS and 30% 
(p≤0.05) in plasma. 
 
 
Figure 6.2 Effect of urea on oxygen-dependent K+ influx in HbSS RBCs. HbSS RBCs (50% Hct) were 
equilibrated in Eschweiler tonometers for 15 min at an oxygen tension of 100 mmHg. Experimental pH 
was pH 7.4, adjusted utilising HNO3 in N-MBS and Cl-MBS, but with PCO2 = 43 mmHg in the case of 
BBS and autologous plasma. RBC aliquots were then diluted 10-fold into test tubes pre-equilibrated 
with the same gas mixtures for measurement of K+ influx (extracellular [K+] of 7.5 mM) over 10 min, 
in which KCC activity was altered by addition of urea (750 mM). All influxes were carried out in the 
presence of ouabain (100 µM) and bumetanide (10 µM) to inhibit K+ influx through the Na+/K+ pump 
and NKCC, respectively. Herein, “-U” represents HbSS RBCs was incubated with incubation media (in 
the absence of urea); “+U” represents HbSS RBCs was incubated with incubation media (in the 
























































































6.4 Effect of cell volume on oxygen-dependent KCl cotransport in HbSS 
RBCs 
In this experiment, effect of cell volume on oxygen-dependent KCl cotransport in HbSS 
RBCs was investigated in different incubation media: Cl-MBS, BBS and autologous 
plasma. As shown in Figure 6.3 (a), K+ influxes were significantly greater in 15% 
swollen RBCs, compared with normal volume at PO2 = 677 mmHg. The relative 
increases were about 115% (p≤0.01) in Cl-MBS; 35% (p≤0.05) in BBS and 61% 
(p≤0.05) in plasma. 
In Figure 6.3 (b), K+ influxes were also significantly greater in 15% swollen RBCs at 
PO2 = 100 mmHg. The relative increases were about 171% (p≤0.01) in Cl-MBS; 108% 
(p≤0.05) in BBS and 100% (p≤0.05) in plasma. 
 
 
Figure 6.3 Effect of cell volume on oxygen-dependent K+ influxes in HbSS RBCs. HbSS RBCs (50% Hct) were 
equilibrated in Eschweiler tonometer for 15 min at an O2 tensions of: (a) 677 mmHg or (b) 100 mmHg. 
Experimental pH was pH 7.4, adjusted using HNO3 in Cl-MBS, but with PCO2 = 43 mmHg in the case of 
plasma and BBS. RBC aliquots were then diluted 10-fold into test tubes pre-equilibrated with the same 
gas mixtures for measurement of K+ influx (extracellular [K+] of 7.5 mM) over 10 min, in which RBC 
volume was altered anisotonically through addition of water. All influxes were carried out in the 
presence of ouabain (100 µM) and bumetanide (10 µM) to inhibit K+ influx through the Na+/K+ pump 
and Na+-K+-Cl- cotransporter (NKCC), respectively. “NV” represents red cells was in normal volume. 
“SW” represents the changes of flux induced by 15% swollen of HbSS RBCs under anisotonically 


























































































6.5 Effect of incubation media on pH-dependent KCl cotransport in HbSS 
RBCs 
In human bodies, the external pH of RBCs may change in active muscle beds from the 
normal pH value of pH 7.4 to pH 7.0 or 6.5 in vivo (Nielsen et al., 2002; Richardson, 
2000). In this experiment, the effects of incubation media on pH-dependent KCl 
cotransport in HbSS RBCs were investigated. The pH values of incubation media were 
adjusted by utilising HNO3 in Cl-MBS, but the pH value of BBS/plasma was altered by 
gassing with different partial pressures of CO2 (PO2=100 mmHg/PN2=570 
mmHg/PCO2=43 mmHg for pH 7.4; PO2=100 mmHg/PN2=513 mmHg/PCO2=100 
mmHg for pH 7.0; PO2=100 mmHg/PN2=292 mmHg/PCO2=321 mmHg for pH 6.5). In 
all cases, osmolality, pH, extracellular K+ concentration and O2 tension were all 
carefully controlled. 
As shown in Figure 6.4, K+ influxes were significantly greater at pH 7.0 incubation 
compared with pH 7.4. In Cl-MBS, K+ influxes were relatively increased by about 68% 
(p≤0.05), in BBS by about 58% (p≤0.05) and in plasma by about 17% (p≤0.05). The 
results show that KCC in HbSS RBCs is pH-dependent under isotonic conditions. Low 
pH will induce RBCs to swell, however, and part of the acid-induced stimulation of KCC 
may be mediated by this mechanism. 
To further investigate the effect of incubation media on pH-dependent KCl cotransport 
in HbSS RBCs, the right-hand panel of Figure 6.4 gives the pH-dependent components 
of K+ influx (= influx in pH 7.0 incubation media – influx in pH 7.4 incubation media). 
The changes of K+ influxes (pH-dependent fluxes, pHDF) induced by low pH value of 
incubation media were significantly greater in Cl-MBS, followed by BBS and then 
plasma. Herein, comparing influxes changes in BBS with influxes changes in Cl-MBS, 
influxes changes in BBS was 62% lower (p≤0.05), whilst they were 44% decreased 
(p≤0.05) comparing plasma with BBS, and 79% lower (p≤0.05) comparing plasma 
with that in Cl-MBS. 
To summarise, the results confirmed that when the external pH values of incubation 
media were altered between pH 7.4 and pH 7.0, the K+ influx in plasma was less than 
in either Cl-MBS or in BBS, implying that autologous plasma had an inhibitory effect 




Figure 6.4 The effect of external pH on K+ influxes measured in Cl-MBS, BBS and plasma in HbSS 
RBCs volume under isotonic condition. HbSS RBCs (50% Hct) were equilibrated in Eschweiler 
tonometers for 15 min at desired oxygen tension. Experimental incubation media pH(s) were pH 7.4 
and pH 7.0, adjusted by utilising HNO3 in Cl-MBS, but were gassed with PO2=100 mmHg/PN2=570 
mmHg/PCO2=43 mmHg to obtain either pH 7.4 BBS or pH 7.4 plasma and PO2=100 mmHg/PN2=513 
mmHg/PCO2=100 mmHg to obtain either pH 7.0 BBS or pH 7.0 plasma. RBC aliquots were then diluted 
10-fold into test tubes pre-equilibrated with the same gas mixtures for measurement of K+ influx 
(extracellular [K+] of 7.5 mM) over 10 min. All influxes were carried out in the presence of ouabain 
(100 µM) and bumetanide (10 µM) to inhibit K+ influx through the Na+/K+ pump and NKCC, respectively. 






















































6.6 Effect of incubation media on urea-stimulated KCl cotransport in HbSS 
RBCs 
In this experiment, the effects of incubation media on urea-stimulated K+ influxes 
were investigated. In all cases, osmolality, pH, extracellular [K+] and O2 tension were 
all carefully controlled. In HbSS RBCs, in the presence of bumetanide and ouabain, 
urea-stimulated K+ transport is mediated solely by KCC. 
Figure 6.5 shows the effect of autologous plasma in comparison with Cl-MBS and BBS 
on urea-stimulated K+ influx in HbSS RBCs. The two left-hand panels show K+ influx 
in RBCs incubated in the absence/ presence of urea (750 mM). In all cases, K+ influx 
was increased by addition of urea, with relative increase in Cl-MBS, BBS, and plasma 
being 38% (p≤0.05), 59% (p≤0.05), 45% (p≤0.05), respectively.  
The right-hand panel of Figure 6.5 gives the urea-stimulated components of K+ influx 
(= influx in urea-treated RBCs – influx in urea-untreated RBCs). There was no 
significant effect of incubation media on urea-stimulated K+ influxes in HbSS RBCs. 
 
 
Figure 6.5 The effect of urea on K+ influx in HbSS RBCs. HbSS RBCs (50% Hct) were equilibrated in 
Eschweiler tonometer for 15 min at an oxygen tension of 100 mmHg. Experimental pH was pH 7.4, 
adjusted utilising HNO3 in N-MBS and Cl-MBS, but with PCO2 = 43 mmHg in the case of BBS and 
autologous plasma. RBC aliquots were then diluted 10-fold into test tubes pre-equilibrated with the 
same gas mixtures for measurement of K+ influx (extracellular [K+] of 7.5 mM) over 10 min, in which 
KCC activity was altered by addition of urea (750 mM). All influxes were carried out in the presence of 
ouabain (100 µM) and bumetanide (10 µM) to inhibit K+ influx through the Na+/K+ pump and NKCC, 
respectively. USF represents the changes of flux induced by high urea concentration in incubation media. 









































6.7 Effect of incubation media on volume-sensitive KCl cotransport in HbSS 
RBCs 
In this series of experiments, volume-sensitive K+ influxes were investigated. In all 
cases, osmolality, pH, extracellular [K+] and O2 tension were all carefully controlled. 
In HbSS RBCs, in the presence of bumetanide, volume-sensitive K+ transport is 
mediated solely by KCC.  
Figure 6.6 shows the effect of autologous plasma in comparison with Cl-MBS and BBS 
on volume-sensitive K+ influx in HbSS RBCs. The two left-hand panels show K+ influx 
in RBCs shrunken or swollen anisotonically by 15% through addition of hypertonic 
sucrose or water to the incubation media. In all cases, K+ influx was increased on 
swelling, with relative increases in Cl-MBS, BBS and plasma being 543% (p≤0.01), 
232% (p≤0.01) and 147% (p≤0.05), respectively. There was no significant effect of 
incubation media on K+ influxes in shrunken RBCs. Influxes in swollen RBCs, however, 
showed a significant inhibitory effect of BBS and plasma compared to MBS. 
The right-hand panel of Figure 6.6 gives the volume-sensitive components of K+ influx 
(= influx in swollen RBCs – influx in shrunken RBCs). Volume-sensitive K+ influxes 
were significantly greater in Cl-MBS, followed by BBS and then plasma. Comparing Cl-
MBS with BBS, K+ influxes in Cl-MBS were 41% higher (p≤0.05) than that in BBS, 
whilst there were 69% higher (p≤0.01) when influx in Cl-MBS was compared with 







Figure 6.6 The effect of incubation media on volume-sensitive K+ influxes in HbSS RBCs. HbSS RBCs 
(50% Hct) were equilibrated in Eschweiler tonometers for 15 min at an O2 tension of 100 mmHg. 
Experimental pH was pH 7.4, adjusted using HNO3 in Cl-MBS, but with PCO2 = 43 mmHg in the case of 
plasma and BBS. RBC aliquots were then diluted 10-fold into test tubes pre-equilibrated with the same 
gas mixtures for measurement of K+ influx (extracellular [K+] of 7.5 mM) over 10 min, in which RBC 
volume was altered anisotonically through addition of hypertonic sucrose or water. All influxes were 
carried out in the presence of ouabain (100 µM) and bumetanide (10 µM) to inhibit K+ influx through 
the Na+/K+ pump and Na+-K+-Cl- cotransporter (NKCC), respectively. VSF represents the changes of 
flux induced by 15% shrunken/swollen of HbSS RBCs under anisotonic conditions. Histograms represent 















































6.8 Effect of incubation media on pH-dependent KCl cotransport in LK sheep 
RBCs 
In this experiment, the effects of incubation media on pH-dependent KCl cotransport 
in LK sheep RBCs were investigated. The pH values of incubation media were adjusted 
by utilising HNO3 in Cl-MBS, but the pH value of BBS/plasma was altered by gassing 
with different partial pressures of CO2 (PO2=100 mmHg/PN2=570 mmHg/PCO2=43 
mmHg for pH 7.4; PO2=100 mmHg/PN2=513 mmHg/PCO2=100 mmHg for pH 7.0; 
PO2=100 mmHg/PN2=292 mmHg/PCO2=321 mmHg for pH 6.5). In all cases, 
osmolality, pH, extracellular K+ concentration and O2 tension were all carefully 
controlled. 
As shown in Figure 6.7, K+ influxes were significantly greater at pH 7.0 compared with 
pH 6.5 or pH 7.4. In Cl-MBS, comparing K+ influxes at pH 7.4 with pH 7.0 and pH 6.5, 
K+ influxes were relatively increased by about 103% (p≤0.05) and 45% (p≤0.05). In 
BBS, comparing K+ influxes at pH 7.4 with pH 7.0 BBS and pH 6.5, K+ influxes were 
relatively increased by about 44% (p≤0.05) and 25% (p≤0.05). In plasma, comparing 
K+ influxes at pH 7.4 with pH 7.0 and pH 6.5, the K+ influxes were relatively increased 
by about 38% (p≤0.05) and 31% (p≤0.05). The results show that KCC in LK sheep 
RBCs is pH-dependent under isotonic conditions.  
To further investigate the effect of incubation media on pH-dependent KCl cotransport 
in LK sheep RBCs, Figure 6.8 gives the pH-dependent components of K+ influx (= 
influx in pH 7.0 incubation media – influx in pH 7.4 incubation media). The changes 
of K+ influxes (pHDF) induced by low pH value of incubation media were significantly 
greater in Cl-MBS, followed by BBS and then plasma. Compared with Cl-MBS (pHDF1), 
influxes in BBS (pHDF2) were reduced by 37% (p≤0.01), whilst comparing Cl-MBS 
(pHDF1) with plasma (pHDF3) they were 26% reduced (p≤0.05). 
Figure 6.9 compares inflxues at pH 7.4 with pH 6.5 giving the pH-dependent 
components of K+ influx (= influx in pH 6.5 incubation media – influx in pH 7.4 
incubation media, pHDF). Changes were still significantly greater in Cl-MBS, followed 
by BBS and then plasma: 17 % lower in BBS cf Cl-MBS (pHDF4); 46 % lower in plasma 
cf BBS (pHDF5); and 55 % lower comparing plasma with Cl-MBS (pHDF6). 
To summarise, the results confirmed that when the external pH values of incubation 
media were altered from pH 7.4 to either pH 7.0 or pH 6.5, the K+ influx in plasma 
89 
 
was less than either in Cl-MBS or in BBS, implying autologous plasma had a larger 
inhibitory effect on pH-dependent KCl cotransport in LK sheep RBCs. However, at pH 
7.0 when KCC activity was greatest, there was no differences observed in any of the 
incubation media, unlike the case with HbSS RBCs. 
 
 
Figure 6.7 The effect of external pH on K+ influxes measured in Cl-MBS, BBS and plasma in LK sheep 
RBCs volume under isotonic conditions. Sheep RBCs (50% Hct) were equilibrated in Eschweiler 
tonometers for 15 min at the desired oxygen tension. Experimental incubation media pHs were pH 7.4, 
pH 7.0 and pH 6.5, adjusted by utilising HNO3 in Cl-MBS, but were gassed with PO2=100 
mmHg/PN2=570 mmHg/PCO2=43 mmHg to obtain either pH 7.4 BBS or pH 7.4 plasma; PO2=100 
mmHg/PN2=513 mmHg/PCO2=100 mmHg to obtain either pH 7.0 BBS or pH 7.0 plasma; and PO2=100 
mmHg/PN2=292 mmHg/PCO2=321 mmHg to obtain either pH 6.5 BBS or pH 6.5 plasma. RBC aliquots 
were then diluted 10-fold into test tubes pre-equilibrated with the same gas mixtures for measurement 
of K+ influx (extracellular [K+] of 7.5 mM) over 10 min. All influxes were carried out in the presence of 
ouabain (100 µM) and bumetanide (10 µM) to inhibit K+ influx through the Na+/K+ pump and NKCC, 














































Figure 6.8 The effect of incubation media on KCl cotransport in LK sheep RBCs (the pH value of 
incubation media was altered from pH 7.4 to pH 7.0 under isotonic condition). Experimental incubation 
media pHs were pH 7.4 and pH 7.0, adjusted by utilising HNO3 in Cl-MBS, but were gassed with 
PO2=100 mmHg/PN2=570 mmHg/PCO2=43 mmHg to obtain either pH 7.4 BBS or pH 7.4 plasma; 
PO2=100 mmHg/PN2=513 mmHg/PCO2=100 mmHg to obtain either pH 7.0 BBS or pH 7.0 plasma. RBC 
aliquots were then diluted 10-fold into test tubes pre-equilibrated with the same gas mixtures for 
measurement of K+ influx (extracellular [K+] of 7.5 mM) over 10 min. All influxes were carried out in 
the presence of ouabain (100 µM) and bumetanide (10 µM) to inhibit K+ influx through the Na+/K+ 
pump and NKCC, respectively. pHDF represents the changes of flux induced by lower pH of incubation 






















































Figure 6.9 The effect of incubation media on KCl cotransport in LK sheep RBCs when the pH value of 
incubation media was altered from pH 7.4 to pH 6.5 under isotonic condition. Experimental incubation 
media pHs were pH 7.4 and pH 6.5, adjusted by utilising HNO3 in Cl-MBS, but were gassed with 
PO2=100 mmHg/PN2=570 mmHg/PCO2=43 mmHg to obtain either pH 7.4 BBS or pH 7.4 plasma; and 
PO2=100 mmHg/PN2=292 mmHg/PCO2=321 mmHg to obtain either pH 6.5 BBS or pH 6.5 plasma. RBC 
aliquots were then diluted 10-fold into test tubes pre-equilibrated with the same gas mixtures for 
measurement of K+ influx (extracellular [K+] of 7.5 mM) over 10 min. All influxes were carried out in 
the presence of ouabain (100 µM) and bumetanide (10 µM) to inhibit K+ influx through the Na+/K+ 
pump and NKCC, respectively. pHDF represents the changes of flux induced by lower pH of incubation 
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6.9 Effect of incubation media on urea-stimulated KCl cotransport in LK 
sheep RBCs 
In this experiment, the effects of incubation media on urea-stimulated K+ influxes 
were investigated. In all cases, osmolality, pH, extracellular [K+] and O2 tension were 
all carefully controlled. In LK sheep, in the presence of bumetanide and ouabain, urea-
stimulated K+ transport is mediated solely by KCC. 
Figure 6.10 shows the effect of autologous plasma in comparison with Cl-MBS and 
BBS on urea-stimulated K+ influx in LK sheep RBCs. The two left-hand panels show K+ 
influx in RBCs incubated in the absence/ presence of urea (750 mM). In all cases, K+ 
influx was increased by addition of urea, with relative increase in Cl-MBS, BBS, and 
plasma being 184% (p≤0.05), 128% (p≤0.05), 117% (p≤0.05), respectively.  
The right-hand panel of Figure 6.10 gives the urea-stimulated components of K+ influx 
(= influx in urea-treated RBCs – influx in urea-untreated RBCs). There was no 
significant effect of incubation media on urea-stimulated K+ influxes in LK sheep RBCs. 
 
 
Figure 6.10 The effect of urea on K+ influx in LK sheep RBCs. Sheep RBCs (50% Hct) were equilibrated 
in Eschweiler tonometer for 15 min at an oxygen tension of 100 mmHg. Experimental pH was pH 7.4, 
adjusted utilising HNO3 in N-MBS and Cl-MBS, but with PCO2 = 43 mmHg in the case of BBS and 
autologous plasma. RBC aliquots were then diluted 10-fold into test tubes pre-equilibrated with the 
same gas mixtures for measurement of K+ influx (extracellular [K+] of 7.5 mM) over 10 min, in which 
KCC activity was altered by addition of urea (750 mM). All influxes were carried out in the presence of 
ouabain (100 µM) and bumetanide (10 µM) to inhibit K+ influx through the Na+/K+ pump and NKCC, 
respectively. USF represents the changes of flux induced by high urea concentration in incubation media. 







































6.10 Effect of incubation media on volume-sensitive KCl cotransport in LK 
sheep RBCs 
In this series of experiments, volume-sensitive K+ influxes were investigated. In all 
cases, osmolality, pH, extracellular [K+] and O2 tension were all carefully controlled. 
In LK sheep RBCs, in the presence of bumetanide, volume-sensitive K+ transport is 
mediated solely by KCC. 
Figure 6.11 shows the effect of autologous plasma in comparison with Cl-MBS and 
BBS on volume-sensitive K+ influx in LK sheep RBCs. The two left-hand panels show 
K+ influx in RBCs shrunken or swollen anisotonically by 15% through addition of 
hypertonic sucrose or water to the incubation media. In all cases, K+ influx was 
increased on swelling, with relative increases in Cl-MBS, BBS and plasma being 78% 
(p≤0.05), 66% (p≤0.01) and 49% (p≤0.01), respectively. There was no significant 
effect of incubation media on K+ influxes in shrunken RBCs. Influxes in swollen RBCs, 
however, showed a significant effect of incubation media on K+ influxes. 
The right-hand panel of Figure 6.11 gives the volume-sensitive components of K+ 
influx (= influx in swollen RBCs – influx in shrunken cells). Volume-sensitive K+ influxes 
were significantly greater in Cl-MBS, followed by BBS and then plasma. Comparing Cl-
MBS with BBS, K+ influxes in Cl-MBS were 37% higher (p≤0.05) than that in BBS, 
whilst there were 98% higher (p≤0.01) when influx in Cl-MBS was compared with 







Figure 6.11 The effect of incubation media on volume-sensitive K+ influxes in LK sheep RBCs. Sheep 
RBCs (50% Hct) were equilibrated in Eschweiler tonometers for 15 min at an O2 tension of 100 mmHg. 
Experimental pH was pH 7.4, adjusted using HNO3 in Cl-MBS, but with PCO2 = 43 mmHg in the case of 
plasma and BBS. RBC aliquots were then diluted 10-fold into test tubes pre-equilibrated with the same 
gas mixtures for measurement of K+ influx (extracellular [K+] of 7.5 mM) over 10 min, in which RBC 
volume was altered anisotonically through addition of hypertonic sucrose or water. All influxes were 
carried out in the presence of ouabain (100 µM) and bumetanide (10 µM) to inhibit K+ influx through 
the Na+/K+ pump and Na+-K+-Cl- cotransporter (NKCC), respectively. VSF represents the changes of 
flux induced by 15% shrunken/swollen of LK sheep RBCs under anisotonic conditions. Histograms 















































6.11 Discussion and conclusion 
KCC activity is sensitive to various physiological stimuli including oxygen tension, pH, 
urea, bicarbonate and volume in RBCs from many vertebrates including sheep, , 
human and horse (Ellory et al., 1991; Hoffmann & Dunham, 1995; Godart et al., 1997; 
Gibson et al., 2000; Joiner et al., 2004). In order to investigate further the role of 
these physiological stimuli roles in KCC modulation, LK sheep red cells were utilised in 
these series of experiments, as KCC in LK sheep RBCs shares similar properties with 
that in equine RBCs, human HbSS RBCs and human umbilical cord RBCs (Lauf et al., 
1992; Speake et al., 1997; Gibson et al., 2001). Findings in LK sheep RBCs were also 
compared with those in human HbSS RBCs. 
 
6.11.1 Comparison of the KCl cotransporter in LK sheep RBC with that in 
human HbSS RBCs, equine RBCs and human umbilical cord (HbF) RBCs 
A previous study carried out by Godart et al. on HbSS RBCs only investigated the effect 
of autologous plasma under anisotonic conditions, notably hypotonic swelling, which 
is an unlikely occurrence in vivo. In this chapter, the other two main physiological 
stimuli for KCC in vivo, urea and low pH, were examined as well, as they will be more 
significant for KCC function in the circulation. 
Table 6.1 summarises the characteristics of KCC in RBCs from the different species or 
stage of maturity. It can be seen that KCC activities were increased when cells became 
swollen. Also, urea and low pH can increase KCC activity in LK sheep RBCs, equine 
RBCs, human HbSS RBCs and HbF RBCs. 
To summarise, the previous and present studies suggest that LK sheep RBCs share 
broadly similar properties with human HbSS RBCs, equine RBCs and immature human 
RBCs, in which low pH, urea and anisotonic swelling are three key physiological stimuli 









Table 6.1. Comparison of KCl cotransporter in LK sheep RBCs with that in human HbSS RBCs, equine 
RBCs, and human umbilical cord RBCs. All RBCs were incubated in MBS at 37 °C. KCC activity in equine 
RBCs, human RBCs and HbF RBCs were taken from the following studies: equine: Gibson et al., 1993; 
Gibson et al., 1995; Speake and Gibson, 1997; HbSS: Hannemann et al., 2015 and HbF: Gibson et al., 
2001. “SH” represent 10% shrinkage of red cell volume; “SW” represents 10% swollen of red cell 
volume. DIOA was added at a concentration of 50 μM. N.D. indicates that “no data” was presented for 


















HbF RBCs  
(%) 
pH 7.4 Cl-MBS  
-> pH 7.0 Cl-
MBS 
+110% +300% +220% +275% 
pH 7.4 Cl-MBS  
-> pH 6.5 Cl-
MBS 
+45% +75% +270% N.D. 
Urea 
stimulation 
+184% +152% +860% +700% 
SH -> SW in 
Cl-MBS 
+78% +186% +15% +600% 
 
6.11.2 Variables affecting KCC activity: control experiments on pH, oxygen 
tension, temperature, extracellular [K+] and osmolality 
Technically, the pH value of BBS/plasma is more difficult to alter than that in salines 
buffered with artificial reagents, as it is determined by the partial pressures of CO2 
and the concentration of bicarbonate. pH, as an important physiological stimulus in 
vivo, plays an important role in modulating KCC activity – for example, low pH is 
encountered in active muscle beds. Hence, uniquely in this study, a Wösthoff gas 
mixing pump was utilised to control accurately the partial pressures of CO2 over the 
physiological range of extracellular pHs.  
According to Campbell and Gibson in 1998, PO2 values over the physiological range 
can also affect the activity of KCC, presenting a sigmoidal relationship, which is 
probably altered by the O2 saturation of Hb (Campbell & Gibson, 1998). Hence, in this 
study, both blood samples (HbSS RBCs and LK sheep RBCs) were also gassed with 
desired partial pressures of oxygen to control the oxygen-dependent component of 
KCC to remove this potential stimulus of variability. 
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Evidence shows that altered temperature can perturb KCC activity by affecting the 
action of regulatory protein kinases/phosphatases, such as activation of phosphatases 
at high temperature (Khan & Ellory, 2000). Hence, all experiments were carried out in 
the incubation media at 37 °C to remove this stimulus of variability. 
Variations in extracellular [K+] are also associated with changes in KCC activity. In 
RBCs, KCC has an affinity of about 7.5 mM extracellular [K+], also any variation in [K+] 
will alter the effective specific activity of 86Rb+. Hence, before carrying out the 
experiments, the extracellular plasma [K+] of LK sheep were measured. [K+] in plasma 
and artificial salines were all adjusted to 7.5 mM (Brugnara et al., 1986; Brugnara & 
Tosteson, 1987). Also, RBC [K+] was checked to ensure that all experiment samples 
were from LK sheep. 
KCC has been well studied as a volume-sensitive transport system. Therefore, to 
ascertain that the RBC volume was not significantly changed by incubation in different 
incubation media, control experiments measuring the water content of RBCs were also 
carried out (Brugnara et al., 1986; Brugnara & Tosteson, 1987). 
Hence, the effects of any variations in pH, oxygen tension, temperature, extracellular 
[K+] and osmolality on KCC activity in LK sheep RBCs can be ignored in these 
experiments. 
 
6.11.3 Effect of autologous plasma 
In section 6.7 and section 6.10, the effect of incubation media on volume-sensitive K+ 
influx in HbSS RBCs and LK sheep RBCs was investigated, although the effects of 
plasma on volume-sensitive K+ influx in sickle cells have been studied in HbSS red 
cells previously (Godart et al., 1997). In Figure 6.11, substitution of MBS with plasma 
significantly decreased the volume-sensitive K+ influx in LK sheep RBCs, and this effect 
was observed in swollen RBCs where KCl cotransporter was activated. The result 
suggests that sheep plasma has an inhibitory effect on volume-sensitive KCl 
cotransport in LK sheep RBCs, similar to that observed by Godart et al. (1997) and 
the result observed in Figure 6.6 on HbSS RBCs confirmed these findings. Moreover, 
comparing volume-sensitive KCl cotransport in different species’ RBCs (HbSS RBCs  
and LK sheep), substitution of BBS with plasma decreased the fluxes by about 31% 
and 0% on volume-sensitive K+ flux in LK sheep RBCs and HbSS RBCs (Table 6.2), 
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which is consistent with the inhibitory substances in plasma being the bicarbonate/CO2 
buffer. Tables below (Table 6.2, Table 6.3 and Table 6.4) summarise the effect of 
incubation media on volume-sensitive KCl cotransport in LK sheep RBCs and HbSS 
RBCs. In the experiment carried out by Godart et al. in 1997, they utilised 5% CO2 
and 25 mM bicarbonate in their experiments, which gives a pH value of 7.5 rather 
than 7.4 (Godart et al., 1997). Small changes in pH and cell volume at around pH 7.4 
have substantial effects on KCC activity in HbSS RBCs (Brugnara et al., 1986). It may 
be that the part of the inhibitory effect of plasma observed in their work is due to 
these factors. 
 
Table 6.2 Effect of incubation media on volume-sensitive KCl cotransport in LK sheep RBCs and HbSS 
RBCs at pH 7.4, 37 °C (Godart et al., 1997). 
 The influx changes of 
volume-sensitive KCl 
cotransport in LK sheep 
RBCs (%) 
The influx changes of 
volume-sensitive KCl 
cotransport in human HbSS 






















Table 6.3 Effect of Cl-MBS and BBS on KCC in shrunken (SH) and swollen (SW) LK sheep RBCs and 
HbSS RBCs at pH 7.4, 37 °C (Godart et al., 1997). 
 The effect of incubation 
media on KCl cotransport 
in LK sheep RBCs (%) 
The effect of incubation 
media on KCl cotransport in 
human HbSS RBCs (%)  
SH Cl-MBS  
-> SH BBS 
-4% -4% 
SW Cl-MBS  
-> SW BBS 
-11% -59% 
 
Table 6.4 Effect of Cl-MBS and plasma on KCC in shrunken (SH) and swollen (SW) LK sheep RBCs and 
HbSS RBCs at pH 7.4, 37 °C (Godart et al., 1997). 
 The effect of incubation 
media on KCl cotransport in 
LK sheep RBCs (%) 
The effect of incubation 
media on KCl cotransport in 
human HbSS RBCs (%)  









In section 6.6 and section 6.9, the effect of incubation media on urea-sensitive K+ 
influx in HbSS RBCs and LK sheep RBCs was studied. To obtain high KCC activities in 
the effect of incubation media, high urea concentrations (750 mM) were utilised 
(Dunham, 1995). The present study (Figure 6.5 and Figure 6.10) demonstrates that 
in the absence/presence of urea (high concentration), there were no significant effect 
of incubation media on the activity of KCl cotransport both in HbSS RBCs and LK sheep 
RBCs when comparing either Cl-MBS, BBS, or plasma (Table 6.5). The cause might be 
that high urea concentrations mimic RBC swelling through effects on macromolecular 
crowding, which in turn might inhibit regulatory enzymes directly (Speake et al., 1997). 
It is postulated that under these conditions, when KCC activity is maximally activated, 
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that no differences were observed when comparing the effect of different incubation 
media. 
 
Table 6.5 Effect of incubation media on urea-stimulated KCl cotransport in LK sheep RBCs and HbSS 
RBCs at pH 7.4, 37 °C. 
 The influx changes of urea-
stimulated KCl cotransport 
in LK sheep RBCs (%) 
The influx changes of urea-
stimulated KCl cotransport in 










n.s. represent “not significant”. 
 
In section 6.5 and section 6.8, the effect of incubation media on pH-dependent K+ 
influx in HbSS RBCs and LK sheep RBCs was investigated. Table 6.6 summarises the 
effect of incubation media on pH-dependent KCl cotransport in LK sheep RBCs and 
HbSS RBCs at pH 7.4 and pH 7.0. In Figure 6.4 and Figure 6.8, plasma had an 
inhibitory effect on pH-dependent KCl cotransport in HbSS red cells and LK sheep 













Table 6.6 Effect of incubation media on pH-dependent KCl cotransport in LK sheep RBCs and HbSS 
RBCs at pH 7.4 and pH 7.0, 37 °C. 
 The influx changes of pH-
dependent KCl cotransport 
in LK sheep RBCs (%) 
The influx changes of pH-
dependent KCl cotransport in 











In conclusion, findings suggested that KCC activity could be altered by O2, external 
pH, urea, cell volume, buffer salines. This chapter further compared the effect of these 
stimuli in different buffer systems in both HbSS RBCs and sheep RBCs. Unlike the 
situation in horse RBCs, bicarbonate / CO2 buffers had some inhibitory effects on some, 
but not all stimuli. The relative inhibitory effects, however, were considerably smaller 
than those described by Godart et al., 1997, particularly for urea-stimulated and pH-

















7 KCl cotransport and pharmacological modulators 
 
7.0 Introduction 
In human red cells, the major significance of KCC is probably pathological in SCA 
patients as its increased and abnormal activity will result in solute loss, RBC shrinkage 
and hence elevated [HbS], thus promoting HbS polymerisation and sickling.  It may 
therefore represent an important early stage in pathogenesis. Considerable effort has 
therefore been expended on understanding the underlying mechanisms and in the 
design of potential pharmacological inhibitors (Gibson et al., 2015). 
As outlined previously, protein phosphorylation is a key component in regulation of 
KCC activity, in both normal and sickle RBCs from humans and across vertebrate 
species (Jennings & Al-Rohil, 1990; Jennings & Schulz, 1991; Cossins et al., 1994; 
Flatman et al., 1996). Net dephosphorylation of the transporter, or a regulatory protein, 
is associated with higher KCC activity and net phosphorylation with reduced activity 
(Cossins et al., 1994). Notwithstanding, most work has been carried out using more 
or less specific pharmacological inhibitors (staurosporine, genistein, N-ethylmaleimide, 
calyculin A), and the identity of the specific enzymes involved remains unclear (Cossins 
et al., 1994). 
An important breakthrough came when it was found that some cases of hypertension 
were caused by mutations in the WNK kinases (Wilson et al., 2001). It was then shown 
that some cation chloride cotransporters (CCCs) were regulated by two Ste20 group 
kinases, the oxidative stress response kinase 1 (OSR1) and the SPS1-related 
proline/alanine-rich kinase (SPAK or STK39) (Piechotta et al., 2002; Dowd & Forbush, 
2003; Delpire & Gagnon, 2008). Later, from work mainly on epithelia, notably the 
kidney, it was found that the “with no lysine (K)” kinases (WNKs) both stimulated 
NKCC and inhibited KCC in a coordinate way, often working via downstream activation 
of SPAK/OSR1 (De Los Heros et al., 2006; Kahle et al., 2006; Alessi et al., 2014). In 
RBCs, the situation remained unclear until more recently two papers have also 
revealed a role for WNKs in control of both KCC and NKCC. Working principally with 
the HEK293 cell line, but also with human red cells (Rinehart et al., 2009), showed 
that WNK1 inhibition played a role in stimulation of red cell KCC by swelling. Latterly, 
Low’s group has used transgenic mice to identify an excitatory role for WNK1 for OSR1 
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and, in regulation of the coordinate transporter, NKCC, upon deoxygenation (Zheng 
et al., 2019).  
Nevertheless, although in other tissues WNKs have been shown to modulate KCC 
activity, their role in mediating many of the stimuli affecting RBC KCC activity and their 
function in sickle cells remain poorly studied. In this chapter, the pan WNK inhibitor, 
WNK463, was used to assess the role of WNKs in regulation of KCC in RBCs, mainly 
from SCA patients but also from normal individuals, assessing its interaction with less 
specific pharmacological modulators of protein phosphorylation (staurosporine, NEM 
and calyculin A) and with the more physiologically important stimuli (pH, volume, urea, 
and oxygen). Results represent the first demonstration for a pre-eminent role for 
WNKs in modulation of KCC activity in sickle cells, suggesting a potential key target 
for chemotherapeutic modulation. By contrast, pharmacological results suggest that 
participation of the downstream kinases SPAK/OSR1 in regulation of KCC activity was 
lacking. 






















7.2 Effect of WNK463 on KCl cotransport in HbSS RBCs 
In the first series of experiment, the effect of the pan WNK inhibitor WNK463 was 
examined in RBCs from both normal individuals (termed HbAA cells) and patients with 
SCA (termed HbSS cells). Initially, its concentration dependence was investigated. 
WNK463 increased KCC activity in both HbAA and HbSS cells, with an EC50 of 7.9 ± 
1.2 nM and 10.9 ± 1.6 nM, respectively (Figure 7.1a). The time course of the effect 
of WNK463 was also determined. After equilibrating in the presence of WNK463 in 
fully oxygenated conditions for 20 min, the inhibitor significantly increased KCC activity 
by about fivefold (Figure 7.1b). With additional periods of pre-incubation prior to 
oxygen tension equilibration, the stimulatory effect of WNK463 increased, becoming 
maximal after 20 min pre-incubation. On the basis of these preliminary experiments, 
a concentration of 40 nM WNK463 and a pre-incubation time of 30 min were chosen 
for subsequent work. In the absence of Cl-, in N-MBS, K+ influxes were 0.65 ± 0.10 
and 0.70 ± 0.20 mmol.(l cells.h)-1 in normal and sickle red cells in the absence of 
WNK463 and 0.74 ± 0.10 and 0.78 ± 0.15 in its presence (40 nM), means ± S.E.M., 
n = 3 (all n.s.), confirming that the major effect of WNK463 was mediated via KCC 
activity. The following is largely restricted to work in red cells from SCA patients, but 









Figure 7.1 Effect of WNK463 on KCl cotransport (KCC) activity in RBCs from normal individuals (HbAA) 
and patients with sickle cell anaemia (SCA). RBCs from patients homozygous for SCA (20% haematocrit, 
Hct) or healthy individuals (40% Hct) were pre-incubated in N-MBS for 30 min at 37 °C in air in the 
presence of 0–40 nM WNK463, unless stated otherwise. They were then equilibrated in Eschweiler 
tonometers for 20 min in air (150 mmHg O2) in the continued presence of WNK463, after which aliquots 
were diluted tenfold into flux tubes. KCC activity was measured as Cl--dependent K+-influx for 10 min 
at an extracellular [K+] of 7.5 mM. KCC activity is given in mmol.(l cells.h)-1. Ouabain (100 μM) and 
bumetanide (10 μM) were present in all experiments. (a) Effect of 0–40 nM WNK463 on KCC activity. 
KCC activity was normalised to that at 40 nM WNK463 and EC50 calculated using nonlinear regression. 
(b) Effect of duration of pre-incubation with 40 nM WNK463 on KCC activity in HbSS RBCs. Symbols 
represent means ± S.E.M., n = 3. * p < 0.05, ** p < 0.01 compared to RBCs incubated in the absence 
of WNK463. 
 
7.3 Effect of combinations of WNK463 and staurosporine, N-ethylmaleimide 
(NEM), and calyculin A in HbSS RBCs and HbAA RBCs 
Staurosporine (100 μM) represents one of the main protein kinase (PK) inhibitors used 
to stimulate KCC activity in RBCs (Cossins et al., 1994). Its effects were compared 
with those of WNK463 (Figure 7.2). When incubated with each PK inhibitor alone, the 
stimulatory effects of WNK463 and staurosporine were similar, albeit slightly greater 
for WNK463. Sequential application of the two inhibitors also gave similar levels of 
activity although addition of WNK463 before staurosporine appeared to slightly 
increase KCC activity further compared to either inhibitor alone. However, the actual 
increase of KCC activity was only 10.6 ± 5.1% compared to WNK463 alone, suggesting 




Figure 7.2 Effect of staurosporine and WNK463 on KCC activity in RBCs from patients with SCA. RBCs 
(20% Hct) were pre-incubated in N-MBS sequentially for two periods of 30 min in the presence of 
vehicle (DMSO) or drug (WNK463 40 nM or staurosporine 100 μM), as indicated. They were then 
equilibrated in Eschweiler tonometers for 20 min at 150 mmHg in the continued presence of WNK463 
and/or staurosporine and KCC activity measured as described in the legend to Figure 7.1. Histograms 
represent means ± SEM, n = 4. * p < 0.05, ** p < 0.01 compared to RBCs incubated in the absence 
of WNK463; # p < 0.05 between groups as indicated. 
 
A second putative PK inhibitor used to stimulate KCC activity in RBCs has been the 
thiol-reacting reagent N-ethylmaleimide (NEM; 100 μM) (Lauf & Theg, 1980; Hume et 
al., 2000). When compared with WNK463, NEM alone or in combination with WNK463, 
NEM gave significantly lower levels of KCC activity compared to WNK463 alone, 
whether applied prior to or after WNK463 (Figure 7.3). Again, there was no indication 
of additive effects of the two reagents. As NEM/WNK463 combinations always reduced 
KCC activity below that of WNK463 alone, it suggested that effects other than PK 
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Figure 7.3 Effect of N-ethylmaleimide (NEM) and WNK463 on KCC activity in RBCs from patients with 
SCA. RBCs (20% Hct) were pre-incubated in N-MBS sequentially for two periods of 30 min in the 
presence of vehicle (DMSO) or drug (WNK463 40 nM or NEM 1 mM), as indicated. They were then 
equilibrated in Eschweiler tonometers for 20 min at 150 mmHg in the continued presence of WNK463 
and/or NEM and KCC activity measured as described in the legend to Figure 7.1. Histograms represent 
means ± S.E.M., n = 4. * p < 0.05, ** p < 0.01 compared to RBCs incubated in the absence of WNK463; 
# p < 0.05 between groups as indicated. 
 
The protein phosphatase inhibitor calyculin A (100 nM) has been shown to inhibit KCC 
activity in RBCs and to prevent subsequent stimulation by PK inhibitors following pre-
incubation with calyculin A (Starke & Jennings, 1993). These observations suggest 
that dephosphorylation of the regulatory site controlling KCC activity involves a 
calyculin A-sensitive phosphatase PP1 and PP2a (Bize et al., 1999, 2000). As observed 
previously, calyculin A on its own inhibited KCC activity below that in control cells 
(Figure 7.4). Following WNK463 addition, however, calyculin A had minimal effect. 
When added prior to WNK463, calyculin A greatly reduced the stimulatory effect of 
subsequent addition of WNK463. These findings are consistent with the WNK 
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Figure 7.4 Effect of calyculin A and WNK463 on KCC activity in RBCs from patients with SCA. RBCs 
(20% Hct) were pre-incubated in N-MBS sequentially for two periods of 30 min in the presence of 
vehicle (DMSO) or drug (WNK463 40 nM or calyculin A 100 nM), as indicated. They were then 
equilibrated in Eschweiler tonometers for 20 min at 150 mmHg in the continued presence of WNK463 
and/or calyculin A and KCC activity measured as described in the legend to Figure 7.1. Histograms 
represent means ± SEM, n = 6. ** p < 0.01 compared to RBCs incubated in the absence of WNK463; 
# p < 0.05, ## p < 0.01 between groups as indicated. 
 
Similar findings were obtained with RBCs from normal individuals (HbAA). Control K+ 
influxes in the absence of protein kinase/phosphatase inhibitors were 0.2 to 0.3 
mmol.(l cells.h)-1. In the presence of staurosporine (100 μM) and NEM (1 mM), these 
increased to 3.41 ± 0.86 and 3.01 ± 0.60 mmol.(l cells.h)-1, respectively. When treated 
with combination of staurosporine or NEM and WNK463 (40 nM), influxes were 3.5 ± 
0.5 and 3.55 ± 0.80 mmol.(l cells.h)-1 (means ± S.E.M, n = 3; N.S. cf staurosporine 
and NEM alone), respectively – showing that the action of WNK463 and 
staurosporine/NEM was not additive. With calyculin A (100 nM), influxes were reduced 
from 0.30 ± 0.07 to 0.20 ± 0.06 mmol.(l cells.h)-1 increasing to 3.40 ± 0.82 with 
WNK463 alone, and in combination with WNK463 after calyculin A, they were 0.43 ± 
0.16 mmol.(l cells.h)-1, showing that pre- treatment of RBCs with the protein 
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7.4 The effect of combinations of WNK463 and physiological stimuli 
modulating KCC activity in HbSS cells 
The effect of changes in pH and volume change and also incubation with high 
concentrations of urea was compared in control HbSS cells and following pre-
incubation with WNK463. All three stimuli significantly elevated KCC activity – as 
shown previously (Gibson & Ellory, 2003) – but none stimulated activity to the extent 
achieved by WNK463 alone (Figure 7.5a–c). Notwithstanding all three were still able 
to increase KCC activity following pre-incubation with WNK463, although the fold 
changes in activity were considerably reduced compared with those in cells not pre-
incubated with WNK463 (Figure 7.5d). These findings may indicate that whilst these 
other stimuli may act mainly through WNK inhibition, their effect must also be 
mediated via some other mechanism, as suggested for the coordinate transport NKCC 
in HEK293 cells (Hannemann & Flatman, 2011). Conversely, it may be that pre-
incubation was insufficient to completely abrogate WNK activity. A similar pattern was 
also found in normal HbAA RBCs. 
In the case of RBC NKCC, WNK1 appears to be responsible for increased activity 
following deoxygenation (Zheng et al., 2019). KCC activity is also oxygen dependent, 
although in a reciprocal fashion being activated by oxygenation rather than 
deoxygenation. In RBCs from normal individuals, KCC is maximally active under 
conditions of full oxygenation, with activity declining as oxygen tension is lowered 
such that the transporter is inactive when cells are fully deoxygenated (Gibson et al., 
1998). In sickle cells, KCC activity has an abnormal oxygen dependence, with highest 
activity in fully oxygenated and fully de-oxygenated cells with a nadir at about the PO2 
required for half maximal saturation of Hb with oxygen (Gibson et al., 1998). This 
abnormal oxygen dependence was confirmed here (Figure 7.6). The interaction of 
WNK and oxygen tension was also investigated. When pre-incubated with WNK463, 
KCC activity was maximally stimulated and became insensitive to changes in oxygen 
tension. These findings suggest a role for WNK in mediating the oxygen sensitivity of 




Figure 7.5 Effect of WNK463 on physiological stimuli of KCC in RBCs from patients with SCA. RBCs 
(20% Hct) were pre-incubated in N- MBS in the presence or absence of WNK463 (40 nM) at 37 °C in 
air. They were then equilibrated in Eschweiler tonometers for 20 min at 150 mmHg, after which aliquots 
were diluted tenfold into flux tubes containing buffers varying in pH, osmolarity, or urea content, all in 
the continued presence or absence of WNK463, and KCC activity was measured as described in the 
legend to Figure 7.1. (a) Effect of WNK463 on pH-dependent KCC activity, n = 6. (b) Effect of WNK463 
on KCC activity in 10% shrunken (SH) or 10% swollen (SW) RBCs, n = 5. (c) Effect of WNK463 on 
urea-induced KCC activity, n = 6. (d) Impact of WNK463 on pH, volume, and urea-stimulated KCC 
activity. Histograms represent means ± SEM of n individual samples. * p < 0.05, ** p < 0.01 compared 












































































































Figure 7.6 Effect WNK463 on oxygen-dependent KCC activity in RBCs from patients with SCA. RBCs 
(20% Hct) were pre-incubated in N-MBS in the presence or absence of WNK463 (40 nM) at 37 °C in 
air. They were then equilibrated in Eschweiler tonometers for 20 min at 0–150 mmHg, after which 
aliquots were diluted tenfold into flux tubes, all in the continued presence or absence of WNK463, and 
KCC activity was measured as described in the legend to Figure 7.1. Symbols represent means ± S.E.M. 
(error bars are smaller than symbols), n = 6. 
 
7.5 The effect of inhibitors of SPAK/OSR1 
In many cases, SPAK/OSR1 are implicated as a downstream target of WNKs. Following 
phosphorylation by WNKs, SPAK/OSR1 then carry out phosphorylation of the relevant 
CCC. The effects of several SPAK/OSR1 inhibitors (STOCK2S-26016, closantel, and 
rafoxanide) as well as of HK01, an inhibitor of MO25, a scaffolding protein that in- 
creases SPAK/OSR1 activity > 100-fold, were investigated. None of these inhibitors, 
however, gave comparable effects to that of WNK463. STOCK2S-26016 and HK01 did 
stimulate a Cl--dependent K+ influx, but effects were minimal (Figure 7.7a and b for 
healthy HbAA RBCs) whilst 40 nM WNK463 increased it about tenfold, from 0.35 ± 
0.04 to 3.1 ± 0.2 mmol.(l cells.h)-1 (n = 24). In comparison, in RBCs from HbSS 
patients Cl--dependent K+-influx increased from 0.48 ± 0.2 to 1.31 ± 0.3 mmol.(l 
cells.h)-1 in the presence of HK01 (p < 0.021; n = 3) and from 0.70 ± 0.10 to 3.3 ± 
0.2 mmol.(l cells.h)-1 (n = 3) in the presence of 40 nM WNK463. Both closantel and 
rafoxanide also increased K+ influx, but in this case, transport was not Cl--dependent 
suggesting a nonspecific increase in membrane permeability rather than stimulation 
of KCC (data not shown). These findings are evidence against a major role for 
SPAK/OSR1 in the phosphorylation pathway modulating red cell KCC activity. 
 






























Figure 7.7 Effect of SPAK/OSR1 inhibitors on KCC activity in HbAA RBCs. RBCs (40% Hct) were pre-
incubated in N-MBS in the presence of 0– 100 μM STOCK2S-26016 or 0–2 mM HK01 at 37 °C in air. 
They were then equilibrated in Eschweiler tonometers for 20 min at 0–150 mmHg, after which KCC 
activity was measured as described in the legend to Figure 7.1. (a) Effect of STOCK2S-26016 on KCC 
activity in HbAA cells, n = 3. (b) Effect of HK01 on KCC activity in HbAA cells, n = 3. Histograms 






































































7.6 Discussion and conclusion 
RBC KCC is sensitive to a number of physiological stimuli including pH, urea, oxygen 
tension and volume (Gibson & Ellory, 2003). These modalities appear to affect the 
transporter by protein (de)phosphorylation (Jennings & Al-Rohil, 1990; Jennings & 
Schulz, 1991), with pharmacological evidence for the presence of both 
serine/threonine and tyrosine phosphoresidues (Cossins et al., 1994; Bize et al., 1999). 
This chapter provides additional demonstration of a functional role for WNKs in control 
of KCl cotransport in RBCs from SCA patients and normal individuals. 
The present work makes use of the pan WNK inhibitor, WNK463. This inhibitor 
produced a marked activation of KCC with an EC50 of around 10 nM, which is about 
the concentration reported in the literature for a specific effect on WNKs. The EC50 of 
WNK463 for different WNKs varies and is reported to be 5, 1, 6, and 9 nM for WNKs 
1, 2, 3 and 4, respectively (Yamada et al., 2016). The functional assays of KCC activity, 
however, are insufficiently sensitive to use these small concentration differences to 
identify the main RBC WNK. An important caveat, however, is that definitive proof of 
the role of WNKs awaits phosphorylation studies in mature red cells or knockdown 
assays in nucleated RBC precursors. Nevertheless, as the abnormally high activity of 
KCC in RBCs from sickle cell patients is known to mediate solute loss and decrease in 
cell volume, KCC stimulation induced by WNK463 would be expected to result in 
shrinkage. 
Both hypertonicity and a reduction of internal [Cl-] have been shown to activate WNKs 
(Xu et al., 2000; Zagórska et al., 2007; Richardson & Alessi, 2008) leading to an 
inhibition of KCC activity. In addition, hypotonicity, sometimes in combination with 
high [K+], had the opposite effect, decreasing WNK phosphorylation and activating 
KCC (De Los Heros et al., 2006; Zhang et al., 2016). Here, hypotonicity, low pH, and 
urea were used to increase KCC activity which was increased further by treatment 
with WNK463. Notwithstanding, the sensitivity to these physiological stimuli was 
significantly reduced in the presence WNK463, consistent with the involvement of 
WNKs, and widening the stimuli with which these enzymes are associated. 
Oxygen is another important physiological regulator of KCC in RBCs. Until recently the 
mechanism was unknown although Hb represented the most obvious sensor (Gibson 
et al., 2000). DeoxyHb has profound effects on red cell function, acting largely through 
114 
 
its greater affinity for the cytoplasmic tail of band 3 (AE1) compared to 
oxyhaemoglobin and from which it displaces several proteins, including several 
glycolytic enzymes and ankyrin (Low et al., 1993; Chu et al., 2016). In a similar way, 
deoxyHb was also recently found to compete with WNK1 following which its release 
into the cytoplasm led to OSR1 activation and subsequent NKCC1 phosphorylation and 
activation (Zheng et al., 2019). As NKCC and KCC are often regulated reciprocally, 
activation of WNK1 by deoxygenation would explain phosphorylation and inactivation 
of KCC. In SCA, however, KCC activity is abnormally high, and its aberrant response 
to deoxygenation – an increase in activity as oxygen tension falls from the P50 of Hb 
to 0 mmHg – may be explained if polymerisation of HbS removes the source of 
deoxyHb for WNK displacement leading to decreased WNK activity. The present 
findings show that inhibiting WNK with WNK643 not only significantly increased KCC 
activity but also abrogated its oxygen dependence.  
Other pharmacological inhibitors of protein phosphorylation also increased KCC activity. 
Staurosporine, which interacts with over two hundred and fifty human kinases with 
varying potency, showed a similar effect to WNK463, whilst a combination of both did 
not appear to be additive. Moreover, it has been shown to inhibit WNK1 directly in 
vitro in an ATP-dependent manner (Yagi et al., 2009), providing a possible mechanism 
for its observed action on KCC activity and lack of any additive effects. NEM acts via 
modification of sulfhydryl group of cysteine residues and has been shown to decrease 
phosphorylation at an established WNK phosphorylation site in SPAK required for its 
activity, as well as at the T1048 equivalent in KCC2 leading to increased activity in 
KCC2 transfected HEK293 cells (Conway et al., 2017). Whilst KCC2 is not present in 
red cells, these findings suggest a possible mechanism for KCC activation by NEM. 
Finally, the effect of WNK inhibition was largely abrogated by pre-treatment with 
calyculin A, indicating a role for protein phosphatases PP1 and PP2A in 
dephosphorylation of the WNK target. 
In conclusion, the present findings confirm the involvement of WNK in negative 
regulation of KCC activity in human RBCs. Whilst this is not a surprise and has been 
shown for several tissues, notably epithelia and neurons, there is little information on 
its role in RBCs aside from a single report on hypotonically induced KCC activity and, 
to date, nothing on sickle cells. In addition, results further emphasise the role of WNKs 
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in influencing KCC activity by important physiological modulators – volume, pH, urea, 
and oxygen tension – extending our understanding of the mechanisms by which KCC 
































8 General discussion 
Since the discovery of SCD by Dr James Herrick in 1910, a plethora of studies on the 
pathogenesis and its protean complications have been suggested. These low-cost SCD 
treatment strategy plans have largely contributed to a longer life span for many SCD 
patients, especially in some developing countries. Hydroxyurea as one of the more 
reliable treatments on SCD, has been approved for use on adults, while the use of HU 
in young SCA patients is usually restricted to more severely affected children (Rees, 
2011). Moreover, more than 30% SCA patients show no response to HU, while in 
others its use it limited because of several deleterious side effects (Strouse & Heeney, 
2012). Therefore, it is important to find out other affordable and milder side effect of 
therapeutic strategies for the treatment of SCD. 
HbS polymerisation and sickling, increased PS exposure and aberrant activity of KCl 
cotransport are critical to the pathogenesis of SCD. However, there is more than one 
factor that affects their behaviour. This thesis mainly addresses a number of 
physiological stimuli and pharmacological stimuli / reagents which contribute to 
sickling, PS exposure and KCC activity, together with potential strategies of inhibiting 
these effects. A better understanding of the role of physiological / pharmacological 
factors controlling these events would inform the development of better SCD 
therapeutic strategies in the future. 
 
8.1 Role of physiological factors in the pathogenesis of SCD 
Taken together, the relative significance of various physiological factors on HbS 
polymerisation, PS exposure and KCC activity were addressed. Table 8.1 summarises 
the effect of these physiological factors. Various in vitro physiological stimuli which, 
such as PO2 per se, rate of deoxygenation, hydrogen ion concentration (pH), urea, 
anisotonicity, medium composition and duration of conditions, have been investigated 
in Chapters 4 - 6.  
The root cause of SCD arises from the polymerisation of HbS to form fibres and distort 
the RBC membrane, eventually resulting in the inability of RBCs to deform effectively 
in the microcirculation, eventually resulting in irreversibly sickled cells, and 
compromising their rheological ability. The lesion of RBC membrane caused by the 
polymerisation of HbS causes them to become rigid, fragile and distorted, which 
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further activates the deoxygenated-induced cation conductance (Psickle). The activation 
of Psickle allows entry of Ca2+ and loss of Mg2+, which induces the externalisation of PS, 
activates the Gardos channel and affects KCC activity. Furthermore, loss of K+ / Cl- 
and water, via Gardos channel or KCC activation, leads to cell dehydration, shrinkage 
and death. There is a role for band 3 in these events with altered binding of HbS to 
its N-terminal of band 3 causing further permeability abnormalities (Gibson & Ellory, 
2002). Also, rate of deoxygenation can alter the extent of sickling, PS exposure and 
KCC activity in HbSS RBCs. 
Regulation of extracellular pH is also important to SCD pathogenesis and management. 
Low pH commonly occurs in metabolic acidosis SCA patients. HbS molecules have a 
decreased solubility at lower pH, with a resulting increase in the driving force for HbS 
polymerisation and Psickle activity (Ueda & Bookchin, 1984) and elevation of KCC 
activity. Ca2+ entry and Mg2+ loss will further increase externalisation of PS and 
activation of KCC, contributing to pathogenesis. 
Urea supplementation was proposed by Murayama’s group in 1971 as a potential 
therapy for SCD. The mechanism of sickling involves the formation of intermolecular 
hydrophobic bonds resulting in the polymerisation of HbS and the formation of fibres 
(Murayama, 1966). Urea in vitro plays in a role in inhibiting the gelation of 
deoxygenated sickle HbS via a chemical attack on these hydrophobic bonds, 
preventing sickling and providing a successful and less toxicity treatment for SCD 
(Javid, 1958). Therefore, the prevention of forming HbS fibres leads to inhibit PS 
exposure and its sequalae. However, findings in Chapter 6 suggests urea plays a role 
in stimulating KCC-mediated volume reduction in HbSS RBCs (Joiner et al., 2007). In 
section 6.3, urea is shown to stimulate oxygen-dependent KCC activity at PO2=100 
mmHg. According to Joiner et al., urea stimulates volume-dependent KCC activity in 
HbSS RBCs as well. These results suggest urea may not be a perfect treatment to cure 
SCD, accompanying with the risk of the activation of KCC in HbSS RBCs. On the other 
hand, urea reduces sickling and PS exposure.  Its potential benefit therefore requires 
further re-evaluation. 
Cell volume is another physiological stimulus which may determine the degree of 
sickling, PS exposure and KCC activity in HbSS RBCs. The effect of intracellular [HbS] 
may be manipulated by the osmotic conditions surrounding the RBCs. Hypotonic saline 
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solutions decrease sickling and KCC activity in HbSS RBCs - Chapter 4 and Chapter 6. 
Previous studies have shown the benefit of reducing plasma osmolality in patients 
(Rosa et al., 1980; Carden et al., 2017) and this is still carried out today (Rees, 
personal communication). The present work provides a greater rational basis for its 
use in clinical patients. However, the risk of activation of KCC in HbSS RBCs represents 
an important caveat. 
 






PO2 PO2 ¯, sickling ­ PO2 ¯, PS ­, in the 
presence of extracellular 
Ca2+ (Weiss et al., 
2011) 
PO2 ¯, KCC ­    
(Joiner & Franco, 
2001) 
Rate of deoxygenation Rate ­, sickling ­ Rate ­, PS ­ NT* 
pH pH ¯, sickling ­ pH ¯, PS ­ pH ¯, KCC ­ 
Urea Sickling ¯ PS ¯ KCC ­ 
Anisotonicity Cell volume ­, 
sickling ¯ 
NT* Cell volume ­, KCC ­ 
Medium composition Compared to Cl-MBS, 
sickling ¯ in BBS and 
plasma 
Compared to Cl-MBS,  
PS ¯ in BBS and plasma 
Compared to Cl-MBS, 
KCC ¯ in BBS and 
plasma 
Duration of conditions When PO2 ¯ and time 
­, then sickling ­          
(pH 8.0 - pH 6.5) 
NT* NT* 
Temperature Temperature ­,   
sickling ­ (Iqbal et 
al., 2013) 
Temperature ­, PS ­ 
(Zhang et al., 2018) 
Temperature ­, KCC ­ 
(Khan & Ellory, 2000) 
Cell age Age ­, sickling ­ 
(Papageorgiou et al., 
2018) 
No effect after short-
time incubation 
(Wesseling et al., 2016) 
Age ­, KCC ­ 









8.2 Role of pharmacological factors in the pathogenesis of SCD 
Table 8.2 summarises the effect of these pharmacological factors on the three major 
facets of the pathogenesis of SCD: HbS polymerisation and sickling, PS exposure and 
KCC activity. 
Staurosporine acts a protein kinase inhibitor which is utilised to stimulate KCC activity 
in RBCs. As shown in Table 8.2, staurosporine had no effect on sickling but stimulated 
KCC activity, so similar compounds may therefore not be a good pharmacological 
approach to treat SCD. Calyculin A is a protein phosphatase inhibitor that inhibits KCC 
but had no effect on sickling. WNK463 is pan WNK inhibitor, which can stimulate KCC 
activity but again had no effect on sickling. In Chapter 4, cytochalasin B acting as an 
inhibitor of the binding of G-actin to the RBC membrane and cytochalasin B also 
inhibits sugar transporter which shows no effect on sickling. EDTA is an anticoagulant 
reagent in blood sample, which had an inhibitory effect on PS exposure, while its 
effects on sickling and KCC activity remain to be investigated. A spider venom 
neuropeptide, GsMTx-4, and ruthenium red increased PS exposure in HbSS RBCs, 
although it is likely that these actions were due to some non-specific effect. Their 
effects on sickling and KCC activity were not studied. STOCK2S-26016 and HK01 are 
two SPAK/OSR1 inhibitors which had a modest stimulatory effect on stimulate KCC 
activity, while their effects on sickling and PS exposure remain to be investigated. In 
previous work in HEK293 cell lines, a major role for WNK1 was implicated in control 
of KCC3 activity using RNA interference (RNAi), with less evidence for WNK2 and 
WNK4 (Rinehart et al., 2009). In these cells, WNK1 inhibition activated volume-
sensitive KCC3 activity via dephosphorylation of T991 and T1048. The same residues 
were dephosphorylated in hypotonically induced KCC3 activity in red cells, although 
no evidence was presented for which WNK was involved. Phosphorylation of KCC3 
T1048 – and its equivalent in the other KCC isoforms – was later shown to be mediated 
by SPAK/OSR1 whilst that of T991 was not (De Los Heros et al., 2006; Zhang et al., 
2016), with neither residue being directly phosphorylated by WNK1 or WNK3. In the 
present study, several SPAK/OSR1 inhibitors with different mechanisms of action were 
tested (STOCK2S-26016, HK01, closantel, and rafoxanide), but their impact on RBC 
KCC activity was minimal. 
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Moreover, this apparent paradox could be explained by several observations. When 
either T991 or T1048 were mutated to alanine, KCC activity increased moderately and 
could still be modulated by low internal [Cl-] or volume change. By contrast, 
T991A/T1048A double mutants were highly active, and the incubation medium had 
no further impact. Furthermore, in vitro phosphorylation experiments using purified 
KCC and SPAK or OSR1 showed phosphorylation of T1048 but not T991 (De Los Heros 
et al., 2006; Rinehart et al., 2009), whilst in an ES knock-in model lacking SPAK and 
OSR1 activity, only T991 was phosphorylated (De Los Heros et al., 2006). The effect 
of a siRNA knockdown of WNK1 in HEK293 was less clear. It markedly reduced KCC 
phosphorylation, whilst knockdown of SPAK or OSR1 did not (Rinehart et al., 2009). 
It is unclear, however, if the knockdowns of SPAK and OSR1 were simultaneous or 
separate. If the latter was the case, then one enzyme could have compensated for 
the loss of the other. Should SPAK/OSR1 only be involved in the phosphorylation of 
T1048 but that of both T991 and T1048 are required for a full impact on KCC 
regulation, inhibiting SPAK/OSR1 would be expected to have a much smaller effect 
than inhibiting upstream WNK. Further understanding of the pathways controlling KCC 
in red cells awaits identification of the phosphoresidues involved – and is proposed as 
an important area for future work. 
Overall, Figure 8.1 shows a cartoon that the effects of various physiological stimuli 














Table 8.2 Effect of pharmacological factors on sickling, PS exposure and KCC activity in HbSS RBCs. 
n.s. represents “not significant”. 
Pharmacological factors Sickling Phosphatidylserine exposure KCC activity 
Staurosporine n.s.  ­ 
Calyculin A n.s.  ¯ 
NEM n.s.  ­ 
WNK463 n.s.  ­ 
Cytochalasin B n.s.   
EDTA  ¯  
GsMTx-4  ­  
Ruthenium red  ­  
STOCK2S-26016   ­ 
HK01   ­ 
 
 
Figure 8.1 Schematic diagram to illustrate the main physiological and pharmacological factors affecting 
sickling, phosphatidylserine (PS) exposure and KCl cotransport (KCC) activity in red cells from patients 
with sickle cell disease (SCD). Sickling, PS exposure and KCC activity are all implicated in pathogenesis 
of SCD. Oxygen tension (PO2), rate of deoxygenation (Δ PO2), pH, temperature, urea and bicarbonate 
- each of which occurs normally in the plasma in vivo - all affect the extent of sickling, PS exposure and 
KCC activity - as illustrated - and thereby have an important impact on disease progression.  In addition, 
inhibitors of protein phosphorylation (notably the pan-WNK kinase inhibitor, WNK463, but also N-
ethylmaleimide (NEM) and staurosporine) and of protein phosphatases (calyculin A) have profound 
effects on KCC activity but do not alter sickling. Less is known about their effects on PS exposure, 
though NEM does increase lipid scrambling (Hannemann et al., 2018). Rather, PS exposure is more 




8.3 Other treatments of SCD 
Newer therapeutic approaches to inhibit intravascular sickling can be classified into 
those inhibiting the gelation of HbS upon deoxygenation, those modifying the 
membrane making it less prone to sickling, inhibitors of membrane transport proteins, 
and those improving peripheral perfusion. 
These various approaches are summarised in Table 8.3. Notwithstanding, several are 
not compatible with a possible clinical applicability. Hence, several covalent (such as 
sodium cyanate) and non-covalent inhibitors (such as Fagara zanthoxyloides) may be 
limited by their toxicity. Some other agents which fail to cross the RBC membrane, 
and cannot therefore inhibit sickling, may still inform similar reagents which may have 
a broader clinical application. 
A successful antisickling agent should be easy to administer, and preferably amenable 
to administration orally. Also, it needs to cross RBC membrane and interact with HbS 
or interact with the RBC membrane, without serious side effects. Moreover, it is 
important to prevent deleterious haematological side-effects such as increased 
haemolysis or increased O2 affinity. To date, few reagents in Table 8.3 have come 
close to satisfying these requirements. It is hoped that some of the results of this 
thesis may be used to inform design of better compounds. The beneficial action of 
urea, in particular, may be utilised to create similar membrane permeable low 
molecular weight compounds with similar actions at higher affinity. Likewise, the 
marked stimulatory effect of WNK kinase inhibitors on KCC indicates that development 
of reagents which are able to stimulate RBC WNK kinases may be viable. 
Despite its emergence the “first molecular disease”, it is clear that further research 











Table 8.3 Other therapeutic strategies for SCD (listed by year) 
Treatment Mechanism References 
Blood transfusion Dilution of [HbS] (Cooley, 1927) 
Acetazolamide Increase oxygen affinity (Hilkovitz, 1957) 
Sodium bicarbonate Increase oxygen affinity (Greenberg & Kass, 1958) 
Phenothiazines Inhibit sickling (Hathorn & Lewis, 1966) 
Testosterone Inhibit sickling (Lundh & Gardner, 1970) 
Sodium cyanate Inhibit HbS polymerisation (Gillette et al., 1971) 
Acetylsalicylic acid Increase oxygen affinity (Klotz & Tam, 1973) 
Mechlorethamine Inhibit gelation (Roth et al., 1973) 
Zinc Inhibit sickling (Brewer & Oelshlegel, 1974) 
Fagara zanthoxyloides Inhibit gelation and sickling (Ekong et al., 1975; Poillon & 
Bertles, 1977) 
Alkylurea Inhibit gelation and sickling (Elbaum et al., 1976) 
Aromatic amino acids Inhibit gelation by competition 
for protein-protein contact sites 
(Noguchi & Schechter, 1977) 
Pyridoxal sulphate Inhibit HbS polymerisation (Kark et al., 1978) 
Cetiedil Inhibit sickling (Asakura et al., 1980) 
Methyl acetimidate Inhibit sickling (Chao et al., 1981) 
5-Azacytidine Decreasing [HbS] (DeSimone et al., 1982) 
Piracetam Inhibit sickling (Gini & Sonnet, 1987) 
Pentoxifylline Inhibit sickling (Bilto et al., 1988) 
Bepridil Inhibit sickling (Johnston et al., 1989) 
H74 KCC inhibitor (Ellory et al., 1990) 
p-hydroxybenzoic acid Inhibit sickling (Akojie & Fung, 1992) 
Clotrimazole and derivatives Gardos channel inhibitors (Brugnara et al., 1993) 
Nitric oxide Increase oxygen affinity (Head et al., 1997) 
Anionic Polysaccharides Reduce adhesion of sickle 
RBCs 
(Barabino et al., 1999) 
Magnesium pidolate KCC inhibitor (De Franceschi et al., 2000) 
Monoclonal antibodies to 
alphaVbeta3 
Reduce adehesion of sickle 
RBCs 
(Kaul et al., 2000) 
ICA-17043 (“Senicapoc”) Gardos channel inhibitor (Stocker et al., 2003) 
N-Acetylcysteine Antioxidant (Pace et al., 2003) 
Vanillin pro-drug (MX-1520) Increase oxygen affinity (Zhang et al., 2004) 
5-Hydroxymethyl-2-furfural 
(5HMF or Aes-103) 
Increase oxygen affinity (Safo et al., 2004) 
124 
 
L-glutamine Antioxidant (Niihara et al., 2005) 
Polynitroxyl albumin Inhibit VOC and inflammation (Mahaseth et al., 2005) 
Eptifibatide Anti-platelet (Lee et al., 2007) 
Tinzaparin (heparin) Reduce VOC (Qari et al., 2007) 
Bosentan Reduce VOC (Sabaa et al., 2008) 
INN-298 and INN-312 Increase oxygen affinity (Nnamani et al., 2008) 
Propranolol Reduce adrenaline-induced 
RBC adhesion 
(De Castro et al., 2012) 
Prasugrel Anti-platelet (Wun et al., 2013) 
TD-1 Increase oxygen affinity (Nakagawa et al., 2014) 
Voxelotor (GBT440) Increase oxygen affinity (Oksenberg et al., 2016) 
GBT1118 Increase oxygen affinity (Dufu et al., 2017) 

























One of the aims of this study was a better understanding of the physiological stimuli 
involved in SCD pathogenesis, acting directly on the sickle RBC, and mediated by HbS 
polymerisation, PS exposure and KCC activity, together with an investigation of 
possible pharmacological factors which may ameliorate the complications of SCD 
mediated by such changes. 
The polymerisation of HbS in sickle cells is the underlying cause of all the complications 
of SCD. Chapter Four of this thesis shows various physiological stimuli such as PO2, 
rate of deoxygenation, pH, urea, anisotonicity, medium composition clearly affect the 
extent of polymerisation of HbS and sickling. Furthermore, although some 
pharmacological reagents such as staurosporine, calyculin A, NEM, WNK463 and 
cytochalasin B, showed no effect on HbS polymerisation and sickling, they might be 
useful in modulation of protein phosphorylation and thus of KCC activity, which will 
remain an area for future investigation. 
A further critical part of SCD pathogenesis is PS exposure, as along with HbS 
polymerisation and the sickling shape change, it will also promote microvascular 
occlusion. Chapter Five of this thesis shows that various physiological stimuli such as 
rate of deoxygenation, pH, urea, medium composition clearly affect the extent of 
externalisation of PS, and may represent valuable avenues for future study. 
Altered membrane cation permeability is also key to pathogenesis as it causes 
shrinkage. The relationship between KCC and some of its physiological modulators 
was considered in Chapter 6. Again, pH, urea, volume and medium composition are 
key physiological stimuli which can regulate KCC in HbSS RBCs. 
Finally, the aim of Chapter 7 was to investigate the role of WNK/SAPK/OSR1 pathway 
in sickle cells. A major stimulatory effect of the pan WNK inhibitor - WNK463 - indicates 
a predominant role for WNK kinases in control of RBC KCC activity. In Chapter 7, some 
other kinases inhibitors such as staurosporine, NEM, calyculin A were utilised in 
combination with WNK463 to explore their roles in WNK/SAPK/OSR1 pathway. Results 
indicated a hierarchy of control with WNK kinases predominant in regulation of KCC.  
A more complete understanding of the mechanisms will inform pathogenesis whilst 




10 Future work 
 
1. To have a better understanding of the role of KCC phosphoresidue on the regulation 
of KCC, with the possible use of quantitative phosphoproteomics. 
 
2. Use of CRISPR/cas9 and immortalised erythroid cells lines (Bristol Erythroid Line 
Adult; BEL-A) to develop a system amenable to molecular intervention. 
 
3. Use of CRISPR/cas9 shRNA to knockout/knockdown PIEZO1 and SCL4A1 (band 3) 
in each SCD cell lines and in control BEL-A cells without the sickle mutation, to identify 
key molecular mechanisms involved in regulation of KCC activity and probe the identity 
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